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1. Introduction 1.1  Cardiovascular Disease Cardiovascular  disease  is  the  leading  cause  of morbidity  and mortality  in  the Western world [1]. The aim of this research was to design, implement, optimize and  test  novel  magnetic  resonance  imaging  (MRI)  pulse  sequences  to characterize several aspects of cardiovascular disease including: 
• Abdominal aortic plaques  
• Chronic myocardial scar 




















 Kim  et  al  (2001)  and  Selvanayagam  et  al  (2004)  found  a  clear  relationship between  the  transmurality  of  infarction  and  the  likelihood  of  functional recovery after revascularization [19, 20]. He found that if the scar is more than 50 % transmural,  there  is  less  than a 20 % improvement  in contractility after revascularization  (Figure  1.2).  Kwong  et  al  (2008)  studied  the  relationship between major cardiac events (MCE) and the area of infarction measured using LGE  imaging  [21].  He  found  that  even  small  areas  of  infarction  (<2 %  of  left ventricular mass) were associated with a seven‐fold increase in MCE (arrows in Figure 1.3) MRI LGE  imaging has emerged as  the gold  standard  technique  for the  evaluation  of  myocardial  viability.  The  ability  of  LGE  MRI  to  image myocardial  infarction  (MI)  with  such  high  spatial  resolution  is  thus  a  key advantage over other imaging modalities.   
 








Figure  1­3:  Hazard  ratio  for  major  cardiac  events  and  its  relationship  to  LGE  (blue 
markers)  and  wall  motion  score  (red  markers)  as  a  percentage  of  left  ventricle 






necrosis [22]. The lines of ablation are designed to isolate the PVs and block the trigger points of AF and create a barrier to the propagation of the arrhythmia. This procedure is however often unsuccessful and there are many cases where it  has  to  be  re‐performed.  Traditionally  fluoroscopy  and  3D mapping  devices have  been  used  to  monitor  the  ablation  procedure  but  they  are  unable  to visualize the presence, extent or exact location of the ablation lesions, which are used to indicate the procedural success [23, 24]. MRI has recently been used to image  the  areas  of  RF  ablation  using  adapted  LGE  techniques  which  were originally developed  for  imaging ventricular  scar  [25]. MRI has  the advantage that it can visualize the presence and extent of scar and relate this to an exact anatomical  location.  The  extent  of  atrial  scar  has  been  correlated  with  the success  of  the  ablation  procedure  [26]  and  been  used  to  guide  repeat procedures [27].  
1.5  Magnetic Resonance Imaging Magnetic  resonance  imaging  (MRI)  has  great  flexibility  to  manipulate  image contrast  by  employing  different  pulse  sequences  and  using  a  variety  of extracellular  and molecular  contrast  agents.  It  is  also  a  non‐invasive  imaging modality  which  does  not  use  ionizing  radiation.  This  lends  it  to  serial examinations which are required for the diagnosis, monitoring and screening of disease. It however suffers from inherently low signal‐to‐noise (SNR) and there exist  a  vast  range  of  different  pulse  sequences  and  adjustable  parameters, which  make  its  use  challenging  and  needs  well‐trained  radiographers  and physicians.  The  development  and  optimization  of  MRI  pulse  sequences therefore requires detailed investigation to produce optimal image quality and maximize diagnostic information.  
1.6  Thesis Overview 






(QIR)  pre‐pulse  was  developed  [29].  It  consists  of  a  DIR  pulse,  a  time  delay (TI1), a second DIR pulse, a second time delay (TI2) and the imaging read‐out. TI1  and TI2  can be optimized  to  achieve blood  suppression within  a wide T1 range (e.g. 100‐1400 ms). This means that a Look Locker scan is also no longer required  as  blood  suppression  can  be  achieved  before  and  after  contrast administration  using  identical  parameters.  The  QIR  sequence  was  later modified to image a reduced field‐of‐view (rFOV) by applying the two inversion 
pulses in two orthogonal planes [30].   The  QIR  and  rFOV‐QIR  sequences  were  mainly  tested  in  the  carotid  arteries which  exhibit  little  cardiac  motion  and  have  relatively  constant  blood  flow throughout the cardiac cycle. To motivate my work in chapter 3, the limitations of the current QIR implementations are described for vessels such as the aorta which  exhibit  cardiac motion  and  variable  blood  flow  throughout  the  cardiac cycle. The  zoom  imaging  technique  is  also  introduced as  an  alternative  to  the rFOV‐QIR technique for imaging a small FOV [31].  






accelerate  imaging  time  and  achieve  a  small  FOV.  I  found  that  the  blood  SNR and vessel‐wall‐to‐blood CNR,  vessel wall  sharpness  and  image quality  scores for  the  ‘trailing’  QIR  images  were  significantly  improved  compared  to  the ‘traditional‘  QIR  implementation  and  untriggered  QIR  images.  This  work  has extended  the  use  of  the QIR  sequence  to  achieve  pre  and  post  contrast  black blood  scans with  identical  parameters  for  vessels with  variable blood  flow or motion.  






independent  sequence  for  LGE  imaging  which  reduces  the  blood  signal  to improve the detection of scar and the assessment of transmurality.  
Chapter 5 describes my work  to  design  and  test  a  new  sequence  to  improve blood  suppression  in  LGE  images  of  myocardial  scar.  The  dual‐IR  sequence consists of a non‐selective IR pulse, a time delay (TI1), a second non‐selective IR pulse,  a  second  time  delay  (TI2)  and  the  imaging  read‐out.  TI1  and  TI2  are optimized to achieve signal suppression within a defined T1 range. This means that only tissues with very short T1 values will have high signal while the signal from all other T1 species will be suppressed. My hypothesis is that the dual‐IR sequence can null the signal from normal myocardium and reduce the signal in the blood whilst maintaining high signal in the regions of scar.   I  performed  simulations  to  optimize  the  TI1  and  TI2  delays  to  suppress  the signal in the following T1 ranges: 50‐1400 ms, 100‐1400 ms, 200‐1400 ms and 300‐1400 ms  according  to  the patient’s  heart‐rate.  I  then  validated  the  signal characteristics of the IR and dual‐IR sequences in phantom experiments. I then imaged 12 patients with known myocardial scar at 10, 20 and 30 minutes after contrast administration with the two dimensional (2D) IR sequence and the 2D dual‐IR  sequence  with  different  T1  suppression  ranges  and  at  different  time points. I found that there was significantly improved scar‐to‐blood CNR for the dual‐IR  technique  compared  to  the  IR  technique.  The  dual‐IR  sequence  also gained  higher  confidence  scores  for  scar  detection  and  transmurality assessment  and  resulted  in  more  consistent  assessment  of  scar  size  and transmurality between readers compared to the IR sequence.   






(EP)  information  to  establish  a  correlation  between  areas  of  scar  and conduction pathways.   As with  imaging  of  ventricular  scar,  there  is  often  high  blood  signal  in  the  IR images  which  can  hamper  the  detection  of  scar.  This  means  that  imaging  is often  performed  at  least  25  minutes  after  contrast  administration  which increases  the  overall  scan  time.  I  also  describe  the  causes  of  the  PV  in‐flow artifact  and  several  approaches  to  reduce  its  effect.  This motivates  the  work described  in  chapter  7  in  which  I  evaluated  the  dual‐IR  pre‐pulse  for  LGE imaging of PV and atrial wall scar.   









Requirements for a vessel wall MR sequence include high spatial resolution and 
reliable blood suppression as well as extensive spatial coverage of the vasculature 
within an acceptable scan time. When contrast agents are employed, the area of 
contrast uptake must be clearly visualized and reliably compared with pre-contrast 
images. The ultimate aim of vessel wall imaging is to identify vulnerable plaques 
which are characterized by a thin fibrous cap, a large lipid core, calcification and 
significant inflammatory cell infiltration [10, 39, 40]. An ideal MR imaging strategy 
should therefore include sequences which can a) visualize the lipid core, b) identify 
the fibrous cap and measure its thickness and c) visualize inflammation in the cap 
[11].  
 
Several studies have employed different MR sequences with and without contrast 
agents to characterize plaque components [9, 12-14, 41, 42]. A common approach is 
to combine pre-contrast T1 and T2 weighted TSE imaging and post contrast T1-
weighted imaging along with a post-contrast angiogram (MRA) to visualize the 
lumen of the vessel. Although our study was specifically aimed at developing a 
sequence for the aorta, in this chapter I will also discuss sequences applied to the 
carotid arteries. It should be noted that vessel wall sequences are often tested in these 
vessels in the first instance and later employed to image the coronary arteries which 











The spin echo (SE) sequence has inherent black blood properties. In order for spins 
to produce a signal, they must experience both the 90 ˚ excitation pulse and the 180 ˚ 
refocusing pulse. If blood which has not experienced the 90 ˚ excitation pulse flows 
into the imaging slice during the echo time (TE), this will reduce the signal 
produced. As this cannot always be relied on to null blood signal, there are a number 
of additional measures used to ensure blood suppression which are briefly described 
in this section. 
2.2.1 Spatial Pre­saturation 
Spatial pre-saturation employs a spatially selective saturation band which is applied 
adjacent to the imaging volume. This saturates the signal of the blood flowing into 
the imaging volume [43, 44]. Although this approach is less sensitive to T1 changes 
of blood, it does rely on precise timing to ensure that the suppressed blood is passing 
through the desired imaging slice at the time of image acquisition (Figure 2.1).  
 








The DIR pre-pulse consists of a non-selective 180 ° inversion pulse immediately 
followed by a slice-selective 180° re-inversion pulse, followed by an inversion time 
delay (TI) and the imaging read-out (Figure 2.2) [45, 46]. The static tissue and the 
blood within the slice will experience both 180 ° pulses and their magnetization will 
therefore be almost completely restored. Assuming there is complete blood exchange 
during the TI delay time, at the time of imaging the blood within the slice will have 
only experienced the non-selective 180 ° inversion pulse. During TI, the blood signal 
will also experience T1 relaxation. The TI must be set so that the read-out is timed to 




























Kramer et al (2004) used T1-weighted (pre and post contrast) and T2-weighted 
sequences (pre-contrast) along with an MRA in 23 patients who were undergoing 
surgery for abdominal aortic aneurysm (AAA) [11]. The area of the aneurysm which 
demonstrated significant plaque burden was imaged both before and after contrast 
administration. The study showed that it was possible to identify both thrombus and 
lipid core and fibrous cap on both pre-contrast T1-weighted images (Figure 2.3a). 
There was also fibrous cap enhancement on post-contrast T1-weighted images 
(Figure 2.3b).  
 
The plaque components identified on MR images were found to be in good 
agreement with histopathology performed on the corresponding slice of the aorta 
resected during surgery. In addition there was a greater increase in post-contrast 
enhancement on T1-weighted images in patients in which histology identified an 
infiltration of inflammatory cells within the fibrous cap compared to those without 
inflammation.  
 
Figure 2­3: Pre-contrast (left) and 5 minutes post contrast (right) T1 weighted imaging [11]. 
 
Although there appears to be enhancement of the fibrous cap in the post contrast T1-
weighted image, there is inferior blood suppression compared to the pre-contrast 
image. The approach employed in this study was to maintain the TI which was used 
before contrast administration for the post-contrast imaging. On the one hand this 
ensures parameters are identical for both scans which allows a direct comparison 
between the two images and a reliable assessment of the percentage contrast 
enhancement. However, as the T1 of blood is significantly shortened after contrast 
administration, imaging is no longer performed at the null point of blood, hence the 







An alternative approach is to shorten the TI value for the post-contrast scans to 
ensure the optimal TI is used to achieve blood nulling. There are potential issues 
with this approach though when employing long acquisitions during which the blood 
T1 can change. This means that the optimal TI set at the beginning of the scan may 
no longer achieve good blood suppression at the end of the scan.  
2.2.2.1 Choosing the Correct TI Value to Null Blood 
Before contrast administration, the T1 of blood (T1 blood) can be assumed to be 
constant for most patients. It has been measured as approximately 1200 ms at 1.5 T 
[34, 47, 48]. The following equation can then be used to calculate the optimal TI: 
€ 
TI = T1blood ln(2)  
Equation 2­1 
If the TReff is insufficient to allow for complete T1 recovery before the following 
inversion pulse, then the Fleckenstein formula [49] must be used to calculate the 
correct TI: 
€ 
TI = T1blood [ln(2) − ln(1+ exp(−TReff /T1blood ))] 
Equation 2­2 
2.2.2.2 Look Locker Scans 
After contrast administration, the T1 of blood can be difficult to predict due to its 
dependency on the type of contrast agent, dosage, patient physiology and time after 
contrast. In this case, a Look Locker scan [28] can be performed just prior to 
imaging to choose the optimal TI on a patient specific basis. The Look Locker scan 
is a method of T1 quantification which employs a 180 ° inversion pulse. The signal 
is then sampled at multiple time points during recovery using many low flip angle 
excitations. Due to the application of RF excitation pulses, some fraction of the 
longitudinal magnetization (Mz) is moved into the transverse plane with each 
excitation. The relaxation process is therefore affected and Mz recovers with an 
apparent T1 known as T1* which is less than the true T1. Instead of converging to 
the equilibrium magnetization, M0, Mz converges to M0* where:  
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where TR is the repetition time and α is the flip angle. 
2.2.3 Quadruple Inversion Recovery Pre­pulse 
Because the DIR pre-pulse can only null the blood signal from one T1 species, the 
TI must be changed post-contrast as the T1 of the blood is shortened. To deal with 
this problem, the QIR pre-pulse was developed [29]. It aims to achieve pre and post 
contrast blood signal suppression with identical imaging parameters. It consists of a 
DIR pre-pulse, a time delay TI1 and second DIR pre-pulse, followed by TI2 and the 













Figure 2­4: The QIR pulse sequence as implemented for carotid artery imaging (adapted from 
[29]). 
 
The use of two inversion pulses to achieve simultaneous signal suppression of two 
T1 species has been previously explored and has been used to image the brain and 
the lungs [50, 51]. A 90 ˚ preparation pulse followed by a series of two, three or four 
pulses has also been optimized to null not just two T1 species but an entire range of 






The aim of the QIR pre-pulse is to null the signal of both pre and post contrast blood. 
In the work by Yarnykh et al (2002), rather than setting the two inversion delays 
(TI1 and TI2) to null two specific T1 species, the delays was specifically optimized 
to achieve complete signal suppression for a wide range of T1 values. In this way, it 
is not necessary to know the precise T1 of blood before or after contrast 
administration which means there is no need for a Look Locker scan. Furthermore, 
the QIR technique should be insensitive to changes in the blood T1 during the 
acquisition. 
 
The steady state Mz of blood (Mzb) at the time of imaging in the DIR and QIR 
sequences can be expressed as a function of the delays (TI, TI1 and TI2), and T1 














The TI1 and TI2 delays were optimized to minimize the integral of (MzbQIR)2 
between T1min and T1max for a fixed effective TR (TReff) of 400 and 800 ms. 
Optimizations were performed with T1max always set as 1400 ms and T1min set at 100 
ms and 200 ms. When the QIR pre-pulse was performed with optimized delays, it 
achieved blood signal suppression within a wide T1 range (Figure 2.5a). This 
compares to the DIR sequence which only suppresses the signal from one specific 







Figure 2­5: Plots of the Mzb versus T1 value for a) the QIR and b) the DIR sequence [29].   
Yarnykh et al (2002) tested the signal characteristics of the two sequences by 
imaging a flow phantom with the QIR and DIR sequences. Fluid with four different 
T1 values was pumped through the phantom and the results confirmed that each T1 
fluid was suppressed by the QIR sequence whereas only one species was suppressed 
by the DIR sequence. The QIR sequence with optimized delays was then used to 
image three patients with carotid artery atherosclerosis and compared to the DIR 
technique. The QIR sequence applied pre (Figure 2.6a) and post contrast (Figure 
2.6b) successfully achieved blood suppression with identical parameters and showed 
post-contrast enhancement in the vessel wall (arrow). This is compared to the DIR 
sequence which achieved good blood suppression pre contrast (Figure 2.6c) but 
when applied post contrast with identical parameters exhibited flow related artifacts 
(Figure 2.6d). 
 







Yarnykh et al (2002) also investigated the effect of the DIR and QIR pre-pulses on 
stationary tissue signal. They found that both pre-pulses caused a significant 
reduction in the signal intensity from both MnCl2 solution and bovine muscle 
compared to the unprepared TSE sequence (Figure 2.7). Both the QIR and DIR pre-
pulses reduced the muscle signal more than the signal from MnCl2 solution. The 
typical biexponential shape of the dependence of the signal on TI for muscle 
indicates the presence of the magnetization transfer effect which is the result of 
specific saturation of macromolecular protons by DIR pulses. The signal intensity 
was also shown to be dependent on the TI used in the DIR sequence with a short TI 
allowing less time for recovery of signal after the application of the pre-pulse. They 
found that when the DIR and QIR sequences were used to image patients with 
atherosclerotic plaque that the average percentage contrast enhancement of muscle 
was 32 % in the QIR sequence compared to 19 % in the DIR sequence. The range of 
enhancement in the plaque was 71-113 % in the QIR sequence compared to 54-101 
% in the DIR sequence. This indicated that changing the TI after contrast 
administration can reduce the signal from stationary tissue which could cause an 
underestimation in contrast enhancement. As the QIR sequence can be applied pre 
and post contrast with inversion delays maintained, it appears not to suffer from this 
inaccuracy. 
 
Figure  2­7: Signal intensity measurements (S) normalized to the signal in unprepared TSE 
sequence (S0) for bovine muscle and MnCl2 solution with the QIR pre-pulse and DIR pre-pulse 







The blood suppression in DIR and QIR sequences relies on the complete exchange 
of blood which can be compromised for thick imaging slices, slow or complex flow 
and short TI or TI2 delays. There has been work employing ‘diffusion-sensitizing 
gradients’ (DSG) to suppress the blood signal. This technique has been applied to 
carotid arteries first using a 3D steady state free precession (SSFP) acquisition [54] 
and then with a 2D multi-slice TSE acquisition [55].  
 
The DSG pre-pulse is performed just prior to the imaging readout and consists of  
90 ° - 180 °- 90 ° non-selective pulses combined with a pair of unipolar motion–
sensitizing gradients positioned on either side of the 180 ° pulse (Figure 2.8). The 
first 90 ° pulse tips the magnetization into the transverse plane, after which the 
gradients, which are applied in all three directions, cause an accelerated dephasing of 
flowing spins. The 180 ° pulse flips the magnetization within the x-y plane after 
which the applied gradient causes a refocusing of the spins. The 90 ° then tips the 
magnetization back along the equilibrium direction. A spoiler gradient ensures that 






















The level of gradient sensitization is dependent on the gradient amplitude, duration 
and direction. As well as reducing the signal from moving spins, the DSG module 
can also lead to signal loss in the vessel wall as a result of T2 decay as well as loss of 
signal from diffusion effects rather than flow. To reduce these unintended effects, 
the gradients should ideally be applied at maximum amplitude and minimum 
duration. However, applying the gradients in such a way results in eddy-current 
effects. In an attempt to overcome this problem, the DSG module has recently been 
combined with a DIR preparation and TSE readout [56] which allowed a shorter 
DSG module duration. When applied in volunteers, the DIR-DSG resulted in fewer 
flow related artifacts and no significant difference in vessel wall SNR compared to 
the DIR-TSE technique.  2.3 2D and 3D Imaging 
2D imaging involves applying the excitation pulse simultaneously with a slice 
selective gradient in order to isolate one slice for imaging. 3D imaging involves 
excitation of an entire 3D slab and applying phase encoding in two orthogonal 
directions and frequency encoding along the third. A 3D k-space is filled and a 3D 
Fourier transform is performed to reconstruct a 3D dataset. The advantages of a 3D 
acquisition include an increased SNR and good spatial coverage. It also allows 
thinner slices to be reconstructed which can reduce partial volume effects and to 
detect smaller plaque components compared to a 2D acquisition.  
 
Spatial pre-saturation and DIR and QIR pre-pulses can provide good blood-
suppression when imaging individual 2D slices. However, there may be insufficient 
blood suppression in 3D images due to incomplete blood exchange within the entire 
3D volume. 3D is also time-consuming as phase encoding must be performed in two 
spatial dimensions. A faster alternative is a multi-slice 2D acquisition which acquires 
all the data for one slice location at a time. One advantage of the DSG approach is 
that it does not rely on the complete out-flow of blood and can therefore be applied 







A common application of the black blood vessel wall imaging techniques is to screen 
for aortic plaques. The DIR-TSE technique has been used to create a series of 2D 
transverse imaging slices which extend from the aortic arch to the aorta-iliac 
bifurcation. In order to achieve the imaging time of 20 minutes, the sequence 
acquired 24 slices with a slice gap of 10 mm [57]. For effective screening, it is 
desirable to have no slice gap but this was not possible due to time constraints. One 
way to speed up image acquisition is to image a reduced FOV. This section will 
describe two such techniques. 
2.4.1 QIR with Reduced Field­of­view Imaging 
A modification to the original QIR sequence was implemented in order to achieve 
outer volume signal suppression for a multi-slice approach [30]. Within each DIR 
pulse pair, the two inversion pulses are applied in two orthogonal planes which are 
the imaging plane (‘Z-slice’ in Figure 2.9b) and the slab which is the width of the 
FOV in the phase-encoding direction (‘Y slab’ in Figure 2.9b). The spins within the 
region where the Y slab and the Z-slice intersect are re-inverted (‘re-inverted 
volume’ in Figure 2.9b). The inflowing blood on the other hand only experiences the 
inversions in the Y direction.  




Figure 2­9: QIR with a small FOV implementation a) pulse sequence and b) schematic diagram 







Both single slice and multi-slice versions of the SFQIR were implemented. In 
simulations and phantom studies, the outer volume suppression in the single slice 
technique was found to be superior for shorter TReff values (Figure 2.10a). The 
multi-slice implementation required a longer TR as the entire imaging sequence for 
each slice is applied within the time TReff/Ns where Ns is the number of slices. The 
multi-slice approach therefore requires a longer TReff value. For a constant TReff of 
4000 ms, the outer volume suppression was plotted versus T1 for different Ns 
values. It was found that higher number of imaging slices resulted in improved 









Figure 2­10: Signal in the outer volume as a function of T1value in a) the single slice techn 
ique with different TReff times and b) the multi-slice technique with a constant TReff of 4000 ms 
and different number of slices [30]  
 
The delays used for the experiments presented in Figure 2.10 were optimized to null 
tissue in the outer volume for T1 values between 100 ms and 2500 ms rather than the 
blood signal. The simulated signal values for the blood using these delays was found 
to be suboptimal compared to the signal characteristics obtained with the QIR 











Figure 2­11: Signal characteristics for single-slice SFQIR sequence acquisition with a) delays 
optimized to suppressed outer FOV (solid line) compared to b) and c) delays optimized to null 
blood in T1 ranges 100 and 200 ms to 400 ms respectively (dotted lines) [30].  
 
In volunteer studies in the aorta, they found that the single-slice SFQIR sequence 
achieved good outer volume suppression which helped to reduce the artifacts which 
result from the motion of the abdominal wall (Figure 2.12). This sequence was 
applied with a slice thickness of 4 mm and a non-gated free breathing approach.  
 
Figure  2­12: Imaging of the abdominal aorta with the SFQIR sequence. a: Reference T1-
weighted DIR-FSE image, b: Outer volume suppression achieved with the SFQIR-FSE 
technique and c: Reduced-FOV SFQIR image with improved in-plane resolution. All images 






One limitation of SFQIR is that the level of blood suppression in the multi-slice 
approach is dependent on the number of slices imaged. In addition, the sequence was 
tested in only 4 volunteers for aorta imaging and measurements of the vessel wall 
and blood SNR and CNR were not included. The outer volume signal is not entirely 
eliminated by the sequence, which may risk residual artifacts. The SFQIR sequence 
is still flow-dependent and the slice thickness is thus limited by the need for out-
flow. In the multi-slice approach the authors suggest that the blood suppression is 
aided by the bidirectional saturation of the inflowing blood.  
2.4.2 Zoom Imaging 
Zoom imaging is a method which allows a small FOV to be imaged. It is 
implemented for the TSE technique by applying the slice-selection and refocusing 
pulses in orthogonal planes (Figure 2.13). The 90 ° excitation pulse is applied 
simultaneously with a phase encoding gradient which only excites spins within the 
FOV in the phase-encoding direction [31]. The 180 ° refocusing pulse is applied in 
the slice-select direction. Signal will be generated only from those spins which lie in 
the region which is crossed by both gradients and have experienced both excitation 
and refocusing pulses. As there is no signal generated outside of this region, the 
FOV in the phase encoding direction can be reduced to encompass only this region 
without wrap-around artifacts. Fewer phase encoding steps can thus be employed 


















Hussain et al (2011) performed a study in the abdominal aorta to compare DIR-TSE 
with a full FOV, DIR-TSE with a reduced FOV using zoom imaging and DIR 
combined with SENSE acceleration [58]. They found that zoom imaging reduced the 
imaging time and had no significant difference in CNR or vessel wall sharpness 
compared to full FOV imaging. Although there was a decrease in SNR due to the 
acquisition of fewer phase encoding lines, there was good agreement in vessel wall 
thickness measurement. In comparison, SENSE reduced CNR and resulted in an 
underestimation of the vessel wall thickness compared to the conventional DIR-TSE 
full FOV imaging sequence. 2.5 Blood Flow and ECG­triggering  
Both the DIR and QIR techniques rely on complete blood exchange during TI or TI2 
respectively. Studies have examined the variation of blood flow during the cardiac 
cycle in the aorta and carotid arteries. The velocity of blood can be measured using 
MRI by employing a sequence known as phase contrast (PC) MRI [59-61]. It 
employs a set of bipolar gradients (Figure 2.14). The effect of a gradient is to induce 
a phase shift proportional to the area of the gradient. A positive gradient induces a 
positive phase shift on stationary tissue. As this is followed by a negative gradient 
which is equal in area, the phase shift induced by the positive gradient is cancelled 
out so that the net effect of the two gradient lobes is zero phase shift. As blood is 
moving along this gradient during its application, the net phase shift is proportional 

















When applied to vessels such as the aorta, the velocity of blood can be measured at 
different time points in the cardiac cycle. The flow rate (F) can be calculated at each 
point in the cardiac cycle as:     
Equation 2­7 
where A is the area of the vessel measured in magnitude reconstructed images. 
 
Cheng et al (2003) used PC-MRI to measure the flow at the supraceliac and 
infrarenal levels in the abdominal aorta [63]. They performed the measurements both 
at rest and after exercise. They found that at rest there is a large peak of forward flow 
(point A in Figure 2.15) after about 200 ms. At the infrarenal level, there is then a 
small amount of backward flow or ‘regurgitation’ at about 400 ms (point B). This is 
followed by a period of very little flow for the remainder of the cardiac cycle. After 
exercise, the forward peak is higher and there is no regurgitation. Although the 
period of diastole is shortened at higher heart-rates, the period of systolic flow is 
however maintained at approximately 400 ms.  
 
Figure  2­15: Blood flow measurements in the supraceliac and infrarenal locations in the 






In order to achieve sufficient blood suppression when imaging the aorta, there must 
be complete blood exchange within the TI period, the DIR-TSE sequence is 
triggered on the R-wave of the ECG. The inversion pulse is performed immediately 
after the R-wave so that there will be maximum blood exchange before the imaging 
is performed. The flow profiles in Figure 2.15 indicate that there is maximum flow 
in the centre of the vessel which falls to zero at the edge of the vessel. If there is poor 
blood suppression due to slow flow, these artifacts will often appear at the edges of 
the vessel wall which can mimic vessel wall enhancement. 
 
Harloff et al (2009) performed similar flow measurements in the carotid arteries 
[64]. There is a peak in systole after about 150 ms but, in comparison to the aorta, 
there is a baseline level of flow throughout the entire cardiac cycle (Figure 2.16). 
Carotid artery imaging is often performed without the use of cardiac triggering 
because it can be assumed that whenever the inversion pulse and imaging sequence 
are applied, there will be sufficient flow to allow complete blood exchange to occur. 
There is also little motion of the carotid arteries throughout the entire cardiac cycle, 
so that imaging can be performed at any time in the cardiac cycle without significant 
motion artifact. 
 
Figure 2­16: Mean, maximum and minimum blood velocities over the cardiac cycle measured 















In the original implementation of the QIR sequence described in chapter 2, no ECG 
triggering was performed; the TReff was therefore an independent parameter, which 
was optimized together with TI1 and TI2 to achieve optimal signal suppression 
within the user defined T1 range [29]. I hypothesize that in blood vessels, which are 
subject to cardiac or respiratory motion and/or have variable blood flow such as the 
aorta, image quality and blood suppression may be improved by combining the 
sequence with cardiac triggering and by synchronizing the second DIR pre-pulse 
with systolic blood flow. Thus, the TReff must be set to equal a multiple of the 
patient’s RR interval. I also explored the combination of the new QIR 




Mzb at the start of the imaging readout in the QIR and DIR sequences can be 
predicted by equations 2.5 and 2.6 [29]. Simulations in MATLAB were performed 
using equation 2.6 to plot MzbQIR for all T1 values up to 1400 ms. TReff was set to 
equal the RR-interval for heart-rates between 30 and 120 bpm at 15 bpm intervals. 
For each heart-rate, the optimal values of TI1 and TI2 were calculated by 






and TI2 times were plotted versus the RR interval. A cubic equation was then fitted 
to the curves to enable the optimal TI1 and TI2 times to be predicted for any RR 
interval. For comparison, MzbDIR was also simulated for each heart-rate using 
equation 2.5, with TI values calculated to null the blood signal for pre and post-
contrast T1 values (1200 ms and 200 ms respectively) using the Fleckenstein 
formula [49].  
3.2.1.2 Simulation of the Evolution of Mzb during DIR and QIR sequences 
Equations 2.6 and 2.7 assume that Mzb has reached a steady state between cardiac 
cycles. Further simulations were performed in order to examine the behavior of the 
signal throughout the sequence and to find out how many heartbeats were required to 
reach as steady-state between heartbeats. Assuming that the blood within the 
imaging slice will be replaced each heartbeat, it will only experience the non-
selective inversion pulse(s). In each RR period, blood will therefore experience: 
DIR Sequence: 180 °– TI – TD    
Equation 3­1 
QIR Sequence: 180 °– TI1 – 180 °– TI2 – TD   
Equation 3­2 
where TD is the time between the beginning of the imaging sequence and the 
following inversion pulse. The DIR and QIR pulse sequence diagrams were shown 
graphically in Figures 2.2 and 2.4. 
 
When the DIR and QIR sequences are combined with a zoom readout, it is possible 
that the inflowing blood has also experienced the 90 º excitation pulse which is 
applied with the phase encoding gradient. Simulations were therefore also performed 






DIR Sequence + zoom: 180 °– TI – 90 °- TD    
Equation 3­3 
QIR Sequence + zoom: 180 °– TI1 – 180 °– TI2 – 90 °- TD    
Equation 3­4 
The pulse sequence for the zoom readout is shown graphically in Figure 2.10. 
 
The simulations to examine the evolution of Mzb were performed in MATLAB for a 
heart-rate of 75 bpm. Mzb in the DIR and QIR sequences (with and without zoom 
imaging) was calculated over ten cardiac cycles at regular time intervals of 10 ms 
using equation 3.5 derived from the Bloch equations [65]. 
€ 
Mz(t) = Mze− t /T1 cos(α) + M0(1− e− t /T1 )  
Equation 3­5 
where T1 is the T1 relaxation constant, α is the flip angle and M0 is the equilibrium 
magnetization. Simulations were performed assuming that the blood experiences a) 
only two non-selective inversion pulses and b) the two non-selective inversion pulses 
and the additional 90 º excitation pulse. A low-high phase order was assumed, 
meaning that the first echo in each heartbeat is used to fill the central lines of k-
space. The value of Mzb at beginning of image acquisition was then plotted versus 
T1 for each heartbeat. This was used to examine the number of cardiac cycles 
required for Mzb to reach a steady state.  
3.2.2 Phantom Studies 
A T1 phantom which consisted of tubes containing gel samples made from agarose 
doped with Gadolinium, inserted in a holder filled with a copper sulphate solution 
was scanned using the DIR and QIR sequence on a 1.5 T Achieva clinical scanner 
(Philips Healthcare, Best, The Netherlands) using the body coil for both transmit and 






sequences, the slice selective pulses were removed and only the non-selective pulses 
were applied. 
 
TReff was set to one RR interval for each simulated heart-rate. As in the simulations, 
the TI of the DIR sequence was set to null pre and post-contrast blood for each 
examined heart-rate. The heart-rate optimized TI1 and TI2 delays were used for the 
QIR sequence. Other imaging parameters included: spatial-resolution = 2 x 2 x10 
mm and TR / TE = 10 ms /5 ms. A fast gradient echo (TFE) readout was used with a 
flip angle of 25 ° and a TFE factor of 1 to ensure that T2 effects could be assumed to 
be negligible and that the imaging sequence did not affect the signal characteristics. 
For each phantom image, a corresponding noise scan was acquired with RF and 




(µbackground 2 +σ background 2) /2
 
Equation 3­6 
where µimage is the average signal intensity in a region of interest defined within each 
sample in the image and µbackground and σbackground are respectively the average and 
standard deviation of the signal intensity in the same region of interest in the noise 
image [66]. The phantom was also scanned with no pre-pulses and the TReff set to 
five times the longest T1 species (i.e. 5 x 1400 ms). The SNR measurements from 
this scan were then used to normalize the simulated Mzb values to the fully relaxed 







The clinical QIR pre-pulse was combined with two ECG-triggering methods; 
‘traditional’ and ‘trailing’ ECG-triggering. In the traditional ECG-triggering 
approach (Figure 3.1a), the QIR pre-pulse was performed immediately after the R-
wave followed by the imaging sequence. In an attempt to ensure adequate blood 
exchange during TI2 regardless of the patient’s blood flow characteristics or the TI1 
and TI2 delays, ‘trailing’ ECG-triggering (Figure 3.1b), performed the “second” DIR 
pre-pulse immediately after the R wave, followed by TI2 and the imaging sequence. 
A delay (Ttrail) was then performed followed by the “first” DIR pre-pulse. In order to 
ensure that remaining time was equal to the TI1 delay, Ttrail was calculated using:  
€ 
Ttrail = RR −TI1 −TI2 −Tacq  
Equation 3­7 


























Figure  3­1: The quadruple inversion pre-pulse sequence implemented with a) “traditional” 
ECG triggering and b) with “trailing” ECG-triggering resulting in different amounts of blood 
flow (blue area under the curve) during TI2.  
3.2.4 Volunteer Studies 
Ten healthy subjects were imaged at 1.5 T using a 32-channel coil. This study was 
performed at 1.5 T as it was part of an existing study at this field strength. Firstly 
pre-contrast images were acquired of the abdominal aorta using a multi-slice DIR-
TSE zoom scan. Imaging parameters included: 33 slices, slice thickness = 5 mm, 
inversion slice thickness = 8 mm, FOV = 79 x 201 mm, spatial resolution = 1 x 1 
mm, TSE factor = 25, TE = 5 ms, FA = 90 °, low-high profile order, five start-up 




































the TI was chosen to null blood using the Fleckenstein formula assuming a pre-
contrast blood T1 value of 1200 ms. 
  
Five slices (with best vessel wall depiction on pre-contrast images) were then 
imaged with the DIR pre-pulse replaced by the QIR pre-pulse with heart-rate 
optimized TI1 and TI2 delays and all other imaging parameters maintained. QIR 
scans were performed firstly with “traditional” ECG-triggering (Figure 3.1a) and 
repeated with the “trailing” ECG-triggering method (as described in Figure 3.1b).  
 
10-15 minutes after the injection of 0.2 mmol/kg of Gadovist (Bayer Schering AG, 
Berlin, Germany), the DIR-TSE scan was repeated in the same five slices. The TI 
was set first to the same TI from the pre-contrast DIR-TSE scan and repeated with 
the TI set according to a preceding Look locker scan. The QIR-TSE sequences were 
then performed in the same five slices with the two ECG-triggering methods and TI1 
and TI2 maintained. The QIR-TSE scan was also repeated with the TReff set to the 
patient’s average RR interval but with ECG triggering switched off. In seven 
patients, the post-contrast QIR-TSE sequence was also repeated without zoom 
imaging thereby acquiring the full FOV. To minimize aliasing artifacts fold-over 
suppression was enabled using external saturation bands. The acquisition time per 
slice was 11 heartbeats for the zoom DIR-TSE and zoom QIR-TSE sequences and 30 
heartbeats for the full FOV QIR-TSE sequence. PC velocity encoded images with 
velocity encoding set to 150 cm/s were also acquired perpendicular to the abdominal 







Image analysis was performed on all images. The measurements were an average of 
those calculated in all five slices. The SNR of blood was measured in all the images 
of healthy volunteers using region of interest analysis performed in OsiriX© Medical Imaging  Software  (version  3.2.1,  Los Angeles,  California). Soapbubble software 
was used to the track the path of the vessel wall using edge detection algorithm and 
SNR of the vessel wall was calculated as the average signal intensity of the 
centerline divided by the standard deviation of the signal in a noise region. CNR 
between the vessel wall and blood (CNR(VW/blood)) was calculated as the 
difference between the vessel wall SNR and blood SNR. The vessel wall sharpness was calculated in percent by normalizing the magnitude of the  local change in signal  intensity at  the selected vessel border  to  the average signal  intensity of the centerline of the selected vessel using a Deriche algorithm [67].  
3.2.6 Image Quality Scores 
Image quality was assessed by two blinded, independent, experienced observers. The 
qualitative analysis of the vessel wall was graded for each image (the central slice) 
on a scale from 0 to 4 for the depiction of the aortic vessel wall: 0, vessel wall not 
visualized; 1, insufficient visualization of vessel wall; 2, sufficient visualization of 
vessel wall with significant artifact level; 3, good visualization of vessel wall with 
low artifact level; and 4, excellent image quality.  
3.2.7 Statistical Analysis 
Statistical analysis was performed to compare the quantitative measurements made 
in pre and post contrast sequences using firstly a one-way ANOVA comparison 
followed by a post-hoc Newman-Keuls paired t-test with a confidence interval of 95 






between the two observers were assessed by the Wilcoxon matched-paired signed 
rank test. 
3.2.8 Flow Measurements 
Region of interest analysis was performed on phase-contrast images using 
ViewForum software (Philips Healthcare, Best, NL) to plot the flow-rate versus time 
curves for each subject. The total blood exchange volume during TI2 was calculated 
for the two ECG-triggering methods by calculating the area under the curve during 
TI2 (see Figure 3.1). The total blood exchange volume (V) required during TI2 to 
achieve complete blood exchange was estimated using:  
Equation 3­8 
where A is the area of the aorta (2 cm2 which was the average measurement from PC 
magnitude images in ten volunteers) and t is the inversion slice thickness which was 




The optimal TI1 and TI2 delays from simulations were plotted versus the TReff 
(equal to the RR interval) and a cubic equation was fitted to the curves. This 
equation was programmed in the scanner software to automatically predict the 












Figure  3­2: Optimal TI1 TI2 times for the QIR sequence from simulations of the Bloch 
equations were plotted versus the TReff and fitted with a cubic equation. 
 
The simulated (lines) and measured (points) blood signal characteristics of the DIR 
sequence for different heart-rates for pre-contrast (Figure 3.3a) and post-contrast 
(Figure 3.3b) show that blood is only suppressed for one specific T1 value. The 
results for the QIR sequence (Figure 3.3c) show that in contrast to the DIR sequence, 
the signal is suppressed for all values of T1 greater than approximately 200 ms. 
There is a small variation in signal characteristics with heart-rate which indicate that 




































Figure 3­3: Blood signal characteristics for different heart-rates for a) the pre-contrast DIR 
with TI calculated to null T1 = 1200 ms, b) the post-contrast DIR with TI calculated to null T1 = 
200 ms and (c) the QIR sequence with optimized TI1/TI2 = 560/160 ms for a heart-rate of 45 
bpm, TI1/TI2 = 372/124 ms for a heart-rate of 75 bpm and TI1/TI2 = 275/100 ms for a heart-
rate of 105 bpm. Normalized Mzb values from theoretical simulations (solid lines) and the SNR 
measurements from phantom experiments (points).  
3.3.1.2 Simulation of the evolution of Mzb during the DIR and QIR sequences 
The signal characteristics predicted by equations 2.5 and 2.6 and shown in Figure 3.3 
assume that a steady-state has been reached between heartbeats. Simulations using 
the Bloch equations were used to examine the evolution of Mzb for blood with a T1 
of 100, 200, 700 and 1200 ms during the first ten heartbeats of the sequence for a 
heart-rate of 75 bpm. The pre-contrast DIR sequence employs a TI to null blood with 
a T1 of 1200 ms. It is only by the 6th heart-beat when the Mzb for blood with a T1 of 
1200 ms crosses the zero point at the time of imaging (Figure 3.4a). These 
simulations were also used to calculate the Mzb value at the time of imaging for each 
T1 species between 1 and 1400 ms (Figure 3.4b), which indicate that it takes 
approximately 10 heartbeats to reach a steady-state for all T1 values but that an 














Figure 3­4: a) The evolution of Mzb during the pre-contrast DIR sequence with TI set to 335 ms 
in order to null a T1 value of 1200 ms for T1 of 100, 200, 700 and 1200 ms and a heart-rate of 75 
bpm and b) Mzb versus T1 plots for each heartbeat.   
The equivalent results for the post-contrast DIR sequence show that the Mzb for a T1 
of 200 ms is nulled from the first heartbeat (Figure 3.5a). It still takes 6 heartbeats to 
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Figure 3­5: a) The evolution of Mzb during the post-contrast DIR sequence with TI set to 135 
ms in order to null a T1 value of 200 ms for T1 of 100, 200, 700 and 1200 ms and a heart-rate of 
75 bpm and b) Mzb versus T1 plots for each heartbeat.  
The results for the QIR sequence show that by the sixth heartbeat, the Mzb for a T1 
of 200, 700and 1200 ms are all nulled at the time of imaging (Figure 3.6a). Again it 





































$# "$$$# '$$$# ($$$# )$$$# &$$$#
*"+"$$,-# *"+'$$,-# *"+.$$,-# *"+"'$$,-#
&'$
&(!$
%$%$ %$ %$ %$
)*+$
,-$

















Figure 3­6: a) The evolution of Mzb during the QIR sequence with TI1/TI2 set to 372/124 ms 
for T1 of 100, 200, 700 and 1200 ms and a heart-rate of 75 bpm and b) Mzb versus T1 plots for 
each heartbeat. 
 
It is important to ensure that the Mzb has reached a steady-state between heartbeats 
as a modulation of the signal can cause ghosting artifacts. It was therefore decided to 
use five start-up shots in all the volunteer studies (i.e. data acquired in the first five 
cardiac cycles were disregarded and not used for image reconstruction).  
 
When the DIR and QIR sequences are combined with a zoom readout, it is possible 
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applied with the phase encoding gradient. Simulations which included the 90 º 
excitation pulse showed that as Mzb is brought into the transverse plane, the blood 
signal is completely suppressed for nearly all T1 values. Depending on the 
orientation of the imaging slice and phase encoding gradient, the patient anatomy 
and amount of blood flow in each cardiac cycle, the blood within the imaging slice 
may have experienced the inversion pulses with or without the additional 90º 
excitation pulse. It cannot be predicted whether the blood has experienced the 90º 
excitation pulse from previous heartbeats on an individual patient basis. In this 
study, the QIR delays were therefore optimized assuming that the blood only 
experiences the inversion pulses. Five start-up shots were employed in all studies to 
ensure a steady state had been reached between heartbeats.  
3.3.2 Volunteer Studies 
The zoom read-out allowed a reduced FOV to be imaged in a shorter time without 
fold-over artifacts (Figure 3.7). The ratio of the vessel wall SNR in the zoomed 
images to that in the full FOV images was 0.64 ± 0.09. This is in good agreement 
with the expected ratio of the square root of the total sampling time of 0.6 for the 
zoomed and full FOV images. There was also a significantly higher blood SNR, 
CNR(VW/blood) and vessel wall sharpness in the full FOV images compared to the 
image acquired with zoom imaging (p<0.05) but no significant difference in the 













Figure 3­7: Post-contrast images using the QIR pre-pulse and trailing ECG-triggering with a) 
full FOV imaging (320 x 220 mm) and fold-over suppression and b) a reduced FOV (79 x 220 
mm) zoom imaging.  
 
The heart-rates in volunteers ranged between 55 and 90 bpm. The TI values used in 
the post-contrast DIR ranged from 130 to 160 ms and the T1 values for the blood 
calculated from the Look Locker scans were between 278 and 385 ms. When using 
the DIR pre-pulse the TI value had to be shortened in order to achieve adequate 
blood suppression after contrast administration (Figures 3.8a, 3.8d and 3.8e). In 
comparison, the QIR pre-pulse allowed imaging to be performed pre and post 
contrast using identical pre-pulse parameters. When the QIR pre-pulse was 
combined with “traditional” ECG-triggering, there was suboptimal blood 
suppression (Figures 3.8b and 3.8f). This is particularly important as incomplete 
blood exchange due to slow flow near the vessel wall could mimic vessel wall 
enhancement. There was however consistently good blood suppression in all 
volunteers using the QIR sequence with “trailing” ECG-triggering (Figures 3.8c and 
3.8g). The trailing ECG-triggering approach also resulted in superior blood 


























Figure 3­8: Volunteer images (heart-rate = 75 bpm) through the abdominal aorta. Pre-contrast 
scans: a) DIR-TSE with TI set using the Fleckenstein formula, b) QIR-TSE with “traditional” 
ECG triggering, c) QIR-TSE with “trailing” ECG triggering and post-contrast scans d) DIR-
TSE with TI set using the Fleckenstein formula, e) DIR-TSE with TI set using a preceding Look 
Locker, f) QIR-TSE with “traditional” ECG triggering, g) QIR-TSE with “trailing” ECG 







The total blood exchange volume during TI2 measured from PC imaging for the two 
triggering techniques shows that the inferior QIR blood suppression using the 
traditional ECG-triggering is caused by insufficient blood exchange during TI2 
(Figure 3.9). These results also indicate that the inversion slice thickness could be as 
much as doubled and there would still be sufficient blood exchange within TI2 to 
achieve adequate blood suppression when using the trailing ECG-triggering 
technique. 
Figure 3­9: The total blood exchange volume during TI2 measured from PC imaging for the 
QIR sequence using the two ECG triggering methods. The dotted line indicates the total blood 
exchange volume required during TI2 for an inversion slice thickness of 8 mm.  
3.3.4 Image Analysis and Image Quality Scores 
There was no significant difference found between the image quality scores given by 
the two observers. The image analysis and image quality scores are displayed in 
Figure 3.10. There was no significant difference in pre-contrast blood SNR or 
CNR(VW/blood) between sequences. The pre-contrast vessel wall SNR, vessel wall 
sharpness and image quality scores were however higher with the DIR sequence 



























were no significant differences between the QIR sequences with the two different 
triggering methods when imaging before contrast. 
 
Post-contrast, the DIR-TSE sequence with TI adjusted using a preceding Look 
Locker had improved blood SNR, CNR(VW/blood), vessel wall sharpness and 
image quality scores compared with the DIR-TSE sequence which used the same TI 
as pre-contrast scans (p<0.05). Post-contrast, the QIR technique using “trailing” 
ECG-triggering had significantly lower blood SNR, higher CNR(VW/blood), 
improved vessel wall sharpness and image quality scores compared to the un-
triggered and the “traditional” ECG-triggered QIR scans (p<0.05).  
 
There was no significant difference in the blood SNR, vessel wall SNR, 
CNR(VW/blood) or image quality measurements between the post-contrast DIR-
TSE with TI adjusted using a preceding Look Locker and the QIR scans using the 
“trailing” ECG-triggering method. Vessel wall sharpness was significantly higher in 
the QIR scans using the “trailing” ECG-triggering method compared to the DIR-TSE 
with TI adjusted using a preceding Look Locker (p<0.05).  
 
The percentage contrast enhancement was calculated as the difference between the 
post-contrast and pre-contrast CNR(VW/blood). The enhancement values for the 
DIR with TI adjusted using a preceding Look Locker and for the QIR with trailing 















Figure  3­10: a) Blood SNR measurements, b) vessel wall SNR, c) vessel wall to blood CNR 
measurements, d) vessel wall sharpness measurements and e) image quality scores for each 
acquisition. N.B. All measurements were made on ten volunteers except the post-contrast QIR 
full FOV measurements which were based on seven volunteers. The bars indicate a statistically 
significant difference between measurements according to a one-way ANOVA comparison 
followed by a post-hoc Newman-Keuls paired t-test with a confidence interval of 95 %.  3.4 Discussion 
In this study I have shown that the QIR sequence can be successfully combined with 
zoom imaging to achieve a reduced FOV resulting in a shorter scan-time. In the 
DIR-TSE sequence, it is mandatory to adjust the TI value after contrast 
administration to achieve adequate blood suppression. This requires a Look Locker 
scan to determine the optimum TI value which adds additional scan time. This limits 






acquisition. I have implemented a QIR-TSE sequence with “trailing” ECG-
triggering, which achieved consistently good blood suppression by ensuring that the 
TI2 delay coincides with maximum systolic flow. This sequence does not require a 
Look Locker scan and can be applied together with long multi-slice acquisitions 
without the need of adapting the inversion times. 
 
Limitations include the fact that the volunteers studied had relatively little variation 
in heart-rate. In patients with variable heart-rates, arrhythmia rejection may be useful 
in ensuring that the optimized QIR delays are correctly calculated from the average 
RR interval in equation 3.7. Future studies should also investigate whether the QIR 
sequence improves the visualization of vessel wall enhancement in patients with 
atherosclerosis. Furthermore, I could evaluate the QIR technique in patients who are 
undergoing endarterectomy where plaque is surgically removed from the aorta to 
assess whether the enhancement is more closely related to the degree of fibrosis 
measured in the tissue samples. 
 
 In conclusion, ECG triggering with a “trailing” TI1 delay was found to be vital 
when applying the QIR sequence to vessels, which are subject to motion and/or 








MRI using LGE is the gold standard non-invasive method to measure MI. It is 
arguably this MR technique which has led to the widespread clinical use of cardiac 
MRI over the last decade. Its superior spatial resolution compared with single photon 
emission computed tomography (SPECT) enables more accurate measurement of the 
extent and transmurality of infarction which are crucial for the clinical management 
of patients with MI [18].  
 
LGE imaging is based on the delayed washout of Gadolinium contrast agent from 
infarcted myocardium compared with healthy myocardium. At 10-30 minutes after 
contrast administration, areas of infarction appear hyperintense on T1-weighted 
images. The IR-TFE technique is the most widely used MR-LGE sequence as it 
maximizes the contrast between infarcted and normal myocardium [32]. A number 
of research studies have investigated the optimal sequence parameters, contrast 
agent, contrast dose and timing for the IR-TFE approach. Alternative LGE sequences 
such as PSIR imaging and T1 mapping have also been investigated.  
 
Although IR-TFE, PSIR and T1 mapping techniques achieve high contrast between 
infarcted and uninfarcted myocardium, they can exhibit low contrast between infarct 
and blood. This can make it difficult to identify small subendocardial infarcts and 
accurately measure transmurality. There have been various strategies developed to 
improve the differentiation of infarcted myocardium from blood. This chapter 
presents a summary of this research and identifies the key strengths and drawbacks 








Simonetti et al (2001) compared ten MR sequences in dogs with induced chronic 
myocardial infarction and examined image contrast, signal difference between 
infarcted and normal myocardium (SDinf-myo), SNR, imaging time and the motion 
sensitivity of each technique [32]. The sequences included the segmented IR-TFE 
sequence, the T2-weighted turbo spin echo (TSE) sequence with and without an IR 
pre-pulse and a T1 weighted TSE with and without an IR pre-pulse. All sequences 
had the same spatial resolution. The post-contrast T1 weighted imaging was found to 
be more sensitive than non-contrast T2-weighted techniques and that GE read-out 
was superior to TSE readout. Overall the segmented IR-TFE images produced 
highest SDinf-myo. 
 
The IR-TFE technique (Figure 4.1), employs a 180 ° inversion RF pulse after the R-
wave. Image acquisition is then performed at a certain time delay (TI) after this 
inversion pulse. To reduce motion artifacts, ECG-triggering is employed to time 
image acquisition with mid-diastole when there is least cardiac motion. To reduce 
respiratory artifacts, breath-holding is performed. K-space segmentation is used 
rather than a single-shot approach which requires a long acquisition window and has 
been found to cause motion artifacts. A single shot approach also tends to drive the 
magnetization into a steady-state during the acquisition period and SDinf-myo is 
reduced. By segmenting the acquisition, fewer phase encoding steps are performed 
and so the main determinate of image contrast is the IR pre-pulse. A low flip angle 
between 20 and 30 ° is employed to minimize the effect of the read-out on the signal 
characteristics. Imaging is performed every two heartbeats (TReff = 2 heartbeats) to 





















Gupta et al (2004) investigated the optimization of TI times for LGE imaging. It was 
found that relative signal intensity between infarcted and normal myocardium (SIinf-
myo) is determined largely by the precise timing of the image acquisition at the null 
point of normal myocardium [68]. In this study, the optimal TI was measured in 17 
patients 10-15 minutes after administration of 0.15 mmol/kg of Magnevist using a 
T1 mapping technique. The patients then underwent IR-TFE imaging. It was found 
that SIinf-myo in IR-TFE images varies considerably with the choice of TI (Figure 
4.2). The peak at TI0 corresponds to the null point of normal myocardium. There is a 
sharp drop in SIinf-myo for TI values less than TI0 which indicates that an 
underestimation of TI severely affects the contrast. There is a more gradual but 
nonetheless significant drop at higher TI values. In this study, the optimal TI was 
found to range from 180 to 315 ms. The optimal TI can also vary widely with 
contrast dose and time after contrast administration as well as patient specific factors 
such as patient weight and cardiac and renal function [68]. TI must therefore be 










TI0 is normally determined by performing a Look Locker scan just prior to the IR-
TFE sequence. As described in chapter 3, the Look Locker sequence is used to 
acquire images each with a different TI value [28]. Each image has different signal 
intensity in the myocardium, infarct and blood (Figure 4.3a). TI0 can be estimated by 
choosing the image in which the myocardium signal is most suppressed. 
Alternatively the signal intensity in a region of interest (ROI) in the viable 
myocardium can be plotted as a function of TI where TI0 corresponds to the x-
intercept of this graph (Figure 4.3b).  











There are several factors which influence the choice of contrast agent, dose and 
timing of image acquisition. These include the licensing and cost of the agent as well 
as its physical properties which affect safety and image quality. As there is currently 
no consensus on the optimum contrast agent, dose or timing of LGE imaging, this 
section will examine the current research and guidelines for clinical practice. 
 
Although highly toxic as a free ion, when gadolinium is bound to an organic 
compound, it is generally regarded as safe for use as a MRI contrast agent [69]. The 
properties of the different contrast agents used for LGE imaging are summarized in 
Table 4.1. Contrast agents can be categorized on the basis of the biochemical 
structure of the chelates used to bind the gadolinium ion as either ‘macrocyclic’ or 
‘linear’ (Figure 4.4) [70]. Each contrast agent also has a property known as 
‘relaxivity’ (r1). The relaxivity of a tissue after contrast administration (R1) can be 
calculated as:  
 
€ 
R1 = RT1 + r1 ⋅C  
Equation 4­1 
           
where RT1 is the relaxivity of the tissue before contrast administration and C is the 
concentration of administered contrast agent present in the tissue. The T1 of the 
myocardium after contrast administration can then be calculated as: 





























Generic Name Relaxivity 
(mM-1s-1) 
Magnevist Gadopentetate dimeglumine r1 = 5.3 (2T) 




MultiHance Gadobenate Dimeglumine r1 = 8.1 (1.5 T) 
Dotarem Gadoterate meglumine r1 = 3.4 (1T) 




ProHance Gadoteridol r1 = 3.7 (1T) 
Table 4­1: Contrast agents used in LGE imaging of MI and their properties [69, 70, 72]. 
4.2.5 Nephrogenic Systemic Fibrosis 
Nephrogenic Systemic Fibrosis (NSF) is a severely disabling systemic fibrosing 
condition associated with increased morbidity and mortality. It was first linked with 
Gadolinium contrast agents in 2006 [73]. A causal relationship is yet to be proven 
and there are thought to be a number of additional risk factors. It is also extremely 
rare and has only been reported in patients with impaired renal function [69]. One 
theory proposes that the decreased clearance rate in these patients can allow other 
cations to displace gadolinium from its chelate, releasing free gadolinium which is 
then deposited in various tissues [69]. However, this has not been clinically proven 
















NSF has been most commonly linked to linear chelates. Most reports are for 
Omniscan, followed by Magnevist with fewer reports for the macrocyclic agent, 
Prohance [74-76]. This appears to support the theory that macrocyclic chelates tend 
to bind more tightly to gadolinium chelates compared with linear chelates but it may 
also be because Ominscan has more often been administered in high doses [77]. 
Despite the ongoing controversy surrounding NSF and its association with different 
contrast agents, the European Committee for Medicinal Products for Human Use 
(C.H.M.P.) recently issued advice on Gadolinium contrast agents [78]. They have 
contraindicated the use of high risk gadolinium contrast agents in patients with 
severe renal impairment, patients in the perioperative liver-transplantation period 
and in neonates. They have categorized contrast agents into the following three 
groups according to risk: 
 
• High risk - Omniscan, OptiMARK, Magnevist  
• Medium risk - MultiHance, Primovist, Vasovist  




than  other  chelates  (macrocyclic  and  ionic),  is  shown  undergoing  the  process  of 
transmetallation.  Other  endogenous  cations  such  as  copper,  iron,  Zinc  and  calcium 




Before the first description of NSF, clinical LGE studies were regularly performed 






weight). Although the NSF guidelines contraindicate these agents only in specific 
patient groups, in practice most clinical studies are now performed with ‘low risk’ 
agents. However, research studies are still performed with medium and high risk 
agents. Studies have been performed to compare the image quality when using low 
and medium risk agents with that achieved with Magnevist and Ominscan. As 
contrast agents have different relaxivity and binding, these studies have also 
investigated the optimum dose and image timing. 
4.2.6 Dose of Contrast Agent Used for LGE 
The signal intensity of the myocardium, infarct, blood and other tissues in the IR 
sequence will be dependent on their T1 values at the time of image acquisition. 
Equations 4.1 and 4.2 show that the T1 value is affected by the relaxivity of the 
contrast agent and the concentration present in the tissue. For example Multihance 
has almost double the relaxivity of Magnevist (Table 4.1). Schlosser at al (2005) 
found that a double dose of Multihance produced images with higher CNRinf-myo than 
a double dose of Magnevist but also resulted in an increased blood SNR [80]. 
Subsequent studies compared LGE imaging using a double dose of Magnevist and 
using a single dose (0.1 mmol/kg) of Multihance. In LGE images taken at 10 
minutes, Bauner et al (2009), found higher CNRinf-myo with a single dose of 
Multihance and no significant difference in CNRinf-blood compared with a double dose 
of Magnevist [81]. There was however a significant increase in blood SNR with 
Multihance. In images taken at 15 minutes, Balci et al (2006), found no difference in 
CNRinf-myo or relative SIinf-blood [82].  
 
Papini et al (2010) found that a single dose of Multihance was also found to produce 
higher CNRinf-myo compared to a single dose of Dotarem [83]. Although there was a 
higher blood signal in Multihance images, there was no significant difference in 
CNRinf-blood between the two contrast agents.  
 
Although Multihance produces high CNRinf-myo, it binds weakly to albumin [69] 
which means it remains in the blood pool for longer and has a higher relaxivity upon 
binding. Imaging later after contrast administration may reduce blood signal but can 






Multihance, it is a linear chelate and is therefore categorized as medium risk. This 
means that Multihance is not widely used in the UK for LGE imaging.  
 
Gadovist is now commonly used in the UK. It is a macrocyclic agent and is 
categorized as low risk. There is limited published work on the optimum dose of 
Gadovist for LGE imaging. A recent study in 20 patients compared Gadovist at a 
single dose and Magnevist at a double dose found no difference in total volume of 
myocardium, percentage of myocardial wall involvement, SNR and CNR [84]. 
However, the relaxivity of Gadovist is only slightly higher than Magnevist so a 
single dose may not produce sufficient signal intensity in the infarct. The current 
SCMR guidelines recommend a dose of Gadovist between 0.1 and 0.2 mmol/kg for 
LGE imaging [85]. 
4.2.7 Timing of LGE Imaging after Contrast Administration 
The late enhancement effect is due to the higher signal in infarcted compared to 
normal myocardium. There is higher gadolinium concentration in infarcted 
myocardium partly because the contrast agent volume of distribution (Vd) is higher 
in infarcted myocardium [86]. There are also differences in wash-in and wash-out 
rates between infarcted and normal myocardium. It is thought to be a combination of 
these two phenomena which results in the late enhancement effect. As the 
concentration of Gadolinium in different tissues changes after administration, the T1 
values of infarct, myocardium and blood will also vary with time after contrast 
administration and these will in turn affect the signal characteristics of IR images.  
 
Goldfarb et al (2009) studied the T1 values of tissues in 25 patients with chronic MI 
after the administration of a double dose of Omniscan [87]. Imaging was performed 
with an inversion pulse followed by a series of balanced steady state free precession 
(bSSFP) readouts per breath hold. These images were acquired approximately every 
two minutes after contrast administration. The T1 values of blood pool, healthy 
myocardium and areas of infarction were calculated every minute using 
interpolation. The time course of the average T1 data (Figure 4.6) shows that the 
difference between infarct and viable myocardium and between infarct and blood 
both increase with time. It appears that blood and infarct have different T1 values as 










Figure  4­6:  Average  T1  values  after  a  double  dose  of  Omniscan  for  25  subjects  with 
chronic MIs  
Similar data from Klein et (2004) using a double dose of Magnevist show that 
although scar and blood T1 values are significantly different at all time points after 
contrast administration, scar and blood T1 values are not significantly different 














Figure  4­7:  Average  T1  values  after  a  double  dose  of  Magnevist  for  11  subjects  with 
chronic MI (adapted from [86])  
The above studies both used the Look Locker technique to calculate T1 values and 
are therefore limited by the accuracy of this technique. There appears to be a wide 
variation of T1 values between different patients so the standard deviation of the 
measurements is quite high. It appears that blood has a higher T1 value than infarct 
as early as 10 minutes but this was not found to be significant.  
 
The magnetic field strength causes the T1 values in most tissues to change. Sharma 
et al (2006) compared blood and myocardium T1 values with Ominscan at 1.5 T and 
3.0 T [47]. They found that the T1 is significantly longer for myocardium (but not 
blood) at 3.0 T compared to 1.5 T. The differences in T1 due to field strength are 
reduced following contrast administration. 
 
All the extracellular agents have a similar pharmacokinetics with the exception of 
Multihance which binds slightly to albumin. Therefore, although many of the above 
studies relate to ‘high risk’ contrast agents which are no longer routinely used, it is 
useful to examine the changes in T1 of different tissues with time after contrast 


























relaxivity of the agent and field strength of the MRI scanner will also affect the T1 
values of tissues [47]. 
4.2.8 Scar Quantification 
There are several approaches to scar quantification on IR images. The scar can be 
outlined manually by the user. There have also been several computerized 
approaches applied to the problem of scar quantification (Figure 4.8). These 
approaches start with the outlining of the epicardial and endocardial borders to 
exclude the blood pool and isolate the myocardium. The ‘standard deviation method’ 
requires the user to define a region of interest in the remote myocardium. The scar is 
then defined as the pixels with a signal intensity greater than 2, 3, 4, 5 or 6 times the 
standard deviation of the signal in this region [32, 88, 89]. In the ‘FWHM method’ 
the scar ROI is either defined by the user in the hyperintense myocardium [90] or is 
automatically calculated as a region which has the maximum signal intensity in 10 
contiguous pixels [91].The scar is then defined as all pixels with a signal intensity at 













Figure  4­8: Histogram of  the number  of  pixels with  different  signal  intensities  and  the 
FWHM and standard deviation thresholding methods for scar quantification [91]. 
 
Amado et al (2004) compared the standard deviation, FHWM and manual 
contouring approaches to TTC histological staining in a canine model of MI [92]. 






standard deviation and manual contouring approaches. They found that FWHM 
technique was also more reproducible than manual contouring. Simor et al (2010) 
also found that the FWHM technique was more accurate than the standard deviation 
technique when compared with histological staining [91]. Flett et al (2011) 
performed a study in patients and found that the FWHM technique produced similar 
results to manual contouring and is statistically more reproducible than manual 
contouring or the standard deviation technique [93].  
 
The inaccuracy of the standard deviation method could be due to the signal intensity 
variation at different locations in the normal myocardium due to the different 
distances from the receiver coil. Therefore the threshold can vary with the choice of 
the region of interest in the remote myocardium. The FWHM method always takes 
the highest intensity pixels in the infarct and therefore should be less affected by the 
distance from the receiver coil as only a relatively small ROI is evaluated depending 
on infarct size. Although manual contouring has higher inter-observer variability, it 
has been shown that it is useful for a reader to perform adjustments to the computer 
detected regions to exclude blood pool and regions of microvascular obstruction [94, 
95]. 4.3 Alternative Sequences for LGE Imaging 
4.3.1 PSIR Sequence 
The image contrast achieved using the IR sequence is sensitive to the choice of TI 
time. In clinical practice, 8 to 12 slices are acquired in a short-axis stack each 
requiring a separate breath-hold. As the T1 value of the normal myocardium 
increases with time after contrast administration, the optimal TI also changes. This 
means that the TI used to image slices at the end of the stack may no longer be 
optimal. As shown in Figure 4.9a, the IR technique uses a magnitude reconstruction 
which means that if the TI time is underestimated, the contrast between the infarct 
and normal myocardium is reduced. Kellman et al (2002) developed the PSIR 
sequence to overcome this problem [33]. As shown in Figure 4.9b, the PSIR 
technique uses phase information to preserve the polarity of the magnetization 
meaning that the contrast between infarcted and viable myocardium is less sensitive 












The Look Locker sequence produces a series of images with different inversion 
times. ROI analysis can be used to calculate the T1 value of a particular tissue. T1 
mapping techniques, on the other hand, produce one image in which the signal 
intensity reflects the T1 value of the spins within the voxel. This is achieved by 
plotting the signal intensity in a particular voxel against the TI time and fitting a 
curve using a multi-parametric non-linear least squares fitting algorithm. This is 
performed on a voxel-by-voxel basis in order to produce a map of the T1 relaxation 
values. 
 
The traditional Look Locker approach produces images of the heart in different 
cardiac phases. As the heart undergoes significant morphological deformation during 
the cardiac cycle, the resulting T1 map would be inaccurate. To overcome this 
problem, Messogrolli et al (2004) developed the modified Look Locker Inversion 
Recovery (MOLLI) sequence for T1 mapping in the heart (Figure 4.10) [96]. Each 
single shot image is acquired at the same cardiac phase in mid-diastole when the 
heart is quiescent. After an initial inversion pulse, a single shot image is acquired, 
two further images are acquired in the following two heartbeats in the same phase. A 
period of four seconds is then allowed for complete relaxation of the magnetization 
to its equilibrium value. A repetition of the first three heartbeats is then performed 






second rest period of 4 seconds, this sequence is played out again with a larger still 
delay between the inversion and the image acquisition and five images instead of 
three are acquired. In total this results in eleven images with different TI values all in 
the same cardiac phase. The fitting of this data to a model thus results in an image 
relatively free from cardiac motion artifacts. As this sequence can be performed 




Despite high contrast between the infarct and normal myocardium, at 5-20 minutes 
post-contrast administration, due to their similar T1 values during this time, there is 
often poor contrast between the blood pool and infarct. This can make it difficult to 
assess the size and transmurality of the infarct and to identify small sub-endocardial 
infarcts. Imaging can be performed later after contrast administration (>20 minutes), 
when the contrast concentration in the blood is lower. However, this can reduce 
patient throughput especially if the agent is slowly cleared from the blood due to 
patient physiology.  
4.4.1 Subtractive Techniques 
The endocardial border can be delineated on SSFP ‘cine’ images and used as a visual 
aid to interpret the IR image [97]. It can however be time-consuming to interpret the 
results due to differences between spatial and temporal resolution of the two sets of 
images. The results can also be inaccurate because of differences in image position 







Kellman et al (2005) developed a LGE approach to allow differentiation of infarct 
from blood by exploiting the fact that T2 of blood is much longer than that of acute 
or chronic MI [35]. This sequence, known as multi-contrast delayed enhancement 
(MCODE), combines a PSIR sequence with a T2-weighted image acquisition. The 
two images have identical spatial resolution and slice position and are acquired in the 
same cardiac and respiratory phase which aids spatial registration of the two images. 
 
The T1 weighted PSIR image provides good differentiation between the infarcted 
and normal myocardium due their differences in T1. The T2-weighted image on the 
other hand, displays similar signal intensity for infarcted and normal myocardium 
but higher blood signal. In this way the combination of the two images can aid the 
definition of the endocardial border. The multi-contrast images can be analyzed by 
method of outlining the epi and endocardial borders on the T2 weighted images and 
transferring the contours onto the T1-weighted image to aid infarct delineation. 
There was also the option of overlaying the images and ‘flickering’ between the T1 
and T2 weighted images. The T2 weighted images unfortunately do not exhibit pure 
T2 weighting as there is also some residual T1 weighting from the inversion pre-
pulse. Another drawback is the fact that 3 heartbeats are required to acquire the PSIR 
and T2-weighted images. 
 
This technique has also been extended by interleaving T1 and T2 mapping 
acquisitions [98]. Although T2-weighted images and T2 maps help to distinguish 
infarct from blood, the imaging time is increased and the two images must still be 
overlaid to determine the endocardial border.  
4.4.3 Flow Dependent Black Blood LGE Approaches 
There is therefore interest in developing an imaging sequence which will 
simultaneously null blood and normal myocardium whilst preserving high signal in 
the infarct. One such sequence has been proposed and which prepares the blood and 
myocardium magnetization differently [37]. This sequence, shown in Figure 4.11a, 
consists of a slice-selective inversion pulse (SSIR), followed by a time delay (TD1), 
a non-selective inversion pulse (NSIR), then a second time delay (TD2) followed by 






imaged blood will only experience the non-selective pulse whereas the infarcted and 
viable myocardium will experience both pulses.  






Whereas the IR sequence requires the operator to choose one TI delay time to null 
the healthy myocardium, the SSIR-NSIR requires the selction of two delay times. 
Firstly the TI which is required to null the blood pool is chosen by examining the 
preceeding Look Locker scan. The delay, TD2 is set to equal TIblood. As the 
magnetization of normal myocardium will experience both inversion pulses, the first 
delay, TD1, must be timed so that in combination with the specified TD2, the 






corresponds to the Look Locker image with the lowest signal from normal 
myocardium.  
 
As derived in chapter 2, the Bloch equation describing T1 recovery of Mz is as 
follows: 
€ 
Mz(t) = M0 + (MZ −M0)e−t /T1  
       
If M1 is the magnetization just after the first inversion pulse and M2 is the 
magnetization immediately prior to the second inversion pulse. The first time delay, 











      
 
By considering the value of M2 which is required for the magnetization of the 
normal myocardial cross zero follwoing the time period TD2 after the second 
inversion pulse,TD1 can be related to TI1blood and TInormal using the following 
equation for M2: 
  
            
 
 
For effective blood supression, there must be complete blood exchange out of the 
imaging slice between the slice selective inversion pulse and the imaging sequence. 
This ensures that blood present in the imaging slice at the time of image acquisition 
has only experienced the non-selective inversion pulse.  
 
The SSIR-NSIR sequence was compared to the standard IR technique in three pigs 
with induced MI and twenty six patients with a known history of MI. The authors 
found the CNRinf-blood was higher using the SSIR-NSIR technique compared with the 
IR technique. However, the CNRinf-myo and SNRinf were both decreased using the 
SSIR-NSIR technique. The mean SIblood-myo was significantly, higher in those 
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patients with a a left ventricular ejection fraction less than or equal to 40 % 
compared to those with an ejction fraction greater than 40 %. 
 
Qualitative analysis of patient data showed that experts detected hyperenhancement 
in more segments and a statistically significant increase in the number of scars with 
transmurality between 0-25 % (subendocardial) was observed with the SSIR-NSIR 
technique compared to the IR technique. The experts gave the SSIR-NSIR images 
higher scores for infarct conspicuity but lower confidence values for grading 
transmurality.  
 
The problems with the SSIR-NSIR approach include the flow dependence of blood 
suppression requiring sufficient blood exchange between the two inversion pulses. 
Many of the patients who undergo delayed enhancemnt imaging will have severely 
impaired ejection fraction and the sequence will result in impaired blood 
suppression. Also because it relies on the precise timing of the two inversion pulses 
which are calculated based on TIblood and TInormal, the technique is also sensitive to 
changes in TIblood and TInormal which can change with time after contrast 
administration. 
4.4.4 Diffusion Sensitized Gradients for Black Blood LGE Imaging 
The blood suppression in DIR imaging relies on the complete exchange of blood 
which can be compromised for thick imaging volumes and for in-plane flow. 
Diffusion-Sensitized gradients have been applied to the heart in healthy volunteers 
[99]. The mechanism of blood signal attenuation was found to be the velocity 
encoding effect acting on spins which are moving in a coherent fashion with only a 
slight effect from diffusion on incoherently moving spins. Salerno et al (2009) have 
combined the standard IR sequence with diffusion sensitizing gradients (DP-IR) to 
achieve black-blood LGE images [100].  
 
In a canine model of chronic infarction, there was a greater than 700 % increase in 
CNRinf-blood but a 25 % decrease in SNRinf and a 40 % decrease in CNRinf-myo [36]. 
The DP-IR technique appears to improve the visualization of sub-endocardial 
infarcts in images taken at 5-10 minutes after administration of 0.15 mmol/kg of 






exchange and should be relatively insensitive to changes in the relaxation times. 
Although the blood suppression is clearly effective, there is also reduced 
differentiation between blood pool and healthy myocardium which might make it 















The IR-GE sequence remains the gold standard for LGE imaging of myocardial scar. 
As it is less sensitive to changes in TI, the PSIR approach is also often used 
clinically and in research studies. Both the IR and PSIR sequences null only the T1 
value which relates to healthy myocardium. This results in high contrast between 
scarred and normal myocardium. However, there can be also high signal from other 
T1 species including blood which can result in poor contrast between scar and blood 
pool. In some cases, this can make it difficult to accurately delineate the endocardial 
border which in turn can compromise accurate assessment of scar size and 
identification of small sub-endocardial scars. An alternative pulse sequence has been 
previously developed which uses an additional slice selective inversion to null the 
signal from blood [37]. This approach is however reliant on sufficient blood 
exchange to achieve black blood properties. There is therefore interest in a flow-
independent technique which improves blood suppression in LGE imaging of 
myocardial scar.  
 
I implemented a dual inversion recovery (dual-IR) pre-pulse which was optimized to 
suppress the signal of tissues and blood within a wide T1 range so that only short T1 
species generate a high signal. My hypothesis is that this sequence will allow 






and reducing blood signal, as long as the T1 of blood is greater than that of scar. I 
sought to investigate whether this leads to improved contrast between scar and 
blood, higher confidence in the detection and evaluation of scar as well as more 
consistent scar size and transmurality assessment.  
5.2 Methods  
5.2.1 The Dual­IR Pre­pulse 
The dual-IR sequence is a modification of the QIR sequence described in chapter 3. 
Whereas the QIR sequence consists of two double inversion pre-pulses, the dual-IR 






Figure 5­1: The dual-IR pre-pulse combined with TFE read-out 
5.2.2 Simulations 
5.2.2.1 Optimization of the TI1 and TI2 Delays in the Dual­IR Pre­pulse 
Whereas the aim of the QIR pre-pulse (described in chapter 3) was to suppress only 
the blood signal, I aimed to optimize the dual-IR pre-pulse to suppress the signal 
from tissue as well as blood within a defined T1 range. In the QIR implementation, 
the TI1 and TI2 delays were optimized to minimize the blood signal for T1 values 
between 100 and 1400 ms signal in order to ensure pre and post contrast blood 
suppression. In the dual-IR sequence, the aim is to suppress the signal of healthy 
myocardium and to suppress the signal from blood but it is also important to 















suppression range, the optimization was performed for different suppression ranges 
for different heart rates to examine which produced the best image contrast. I 
decided to optimize the TI1 and TI2 delays in the dual-IR sequence using the same 
approach as in chapter 3 by minimizing the integral of Mzb within a defined 
suppression range using equation 2.5. T1min was varied between 50, 100, 200 and 
300 ms with T1max always set at 1400 ms. The optimal TI1 and TI2 delays were then 
programmed to be automatically calculated by the scanner software based on the 
T1min value selected by the user and the patient’s heart rate.  
5.2.2.2 Simulation of the Evolution of Mz for Tissue and Blood in the IR and 
Dual­IR Sequences 
Equations 2.5 and 2.6 describe the signal characteristics for blood which will only 
experience the inversion pulses. The tissue on the other hand will also experience the 
imaging sequence. In the IR and dual-IR sequences, in each RR period, tissues will 
experience: 
IR Sequence (tissue): 180 °– TI – (α °- TR)*N – TD          
Equation 5­1  
Dual-IR Sequence (tissue): 180 °– TI1 – 180 °– TI2 – (α °- TR)*N – TD     
Equation 5­2 
where α is the imaging flip angle and N is the number of radio frequency (RF) 
excitations and TR is the time between the RF pulses used for imaging. With RR 
being the time between two R-waves, the time between the end of the imaging 
sequence and the following inversion pulse (TD) can be expressed as:  
IR Sequence(tissue): TD = RR – TI – N*TR        
Equation 5­3 







Simulations were performed in MATLAB to examine the evolution of the 
longitudinal magnetization of tissue (Mzt) and that of blood (Mzb) separately. Mzt 
and Mzb were calculated for the IR and dual-IR sequences over ten cardiac cycles 
using equation 5.5 to determine the effect of the pre-pulses and imaging sequence on 
the tissue and blood separately.       
Equation 5­5 
where T1 is the T1 relaxation constant, ∝(t) is the flip angle applied as a function of 
time and M0 is the equilibrium magnetization. For the Mzt simulations, the number 
of RF excitations (N) was set to 13 for imaging every heartbeat and to 25 for 
imaging every two heartbeats. A constant flip angle of 25 º was applied for all 
imaging RF pulses with a TR of 4 ms. A low-high phase order was assumed, 
meaning that the first echo in each heartbeat is used to fill the central lines of k-
space. The value of Mzt at the beginning of image acquisition was plotted versus T1 
for each heartbeat. This was used to examine the number of cardiac cycles required 
for Mzt and Mzb to reach a steady state.  
 
In the IR sequence, the Fleckenstein formula [49] was used to calculate the optimal 
TI to null healthy myocardium for a given heart rate assuming a T1 value of 535 ms 
for the myocardium. In the dual-IR sequence, the TI1 and TI2 delays were optimized 
for each heart rate to null the signal in the T1 range between 200 and 1400 ms. These 
simulations were performed for heart rates of 45, 75 and 105 bpm (imaging every 
heartbeat and every two heartbeats). In the IR sequence, ‘imaging every two 
heartbeats’ refers to applying the inversion pulse and imaging sequence in the first 
heartbeat and then waiting an entire cardiac cycle to allow for T1 recovery. In the 
 
Mz(t) = Mz.e
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dual-IR sequence, ‘imaging every two heartbeats’ refers to allowing the pre-pulse to 
be played out over the time period of two RR intervals. This aims to produce signal 
characteristics that would be achieved at half the heart rate.  
5.2.3 Phantom Studies 
For both the IR sequence (imaging every two heartbeats) and the optimized dual-IR 
sequence (imaging every heartbeat), simulations were performed for different heart-
rates to calculate the signal which is available at the time of imaging for T1 species 
between 1 and 1400 ms. This was calculated once a steady state had been achieved 
between heartbeats. The SNR of different T1 samples was calculated from scans of a 
T1 phantom using the IR and dual-IR sequences at simulated heart rates of 45, 75 
and 105 bpm. The phantom consisted of tubes containing gel samples made from 
agarose doped with Gadolinium, inserted in a holder filled with a copper sulphate 
solution. The samples had T1 values ranging from 140 to 1720 ms. Imaging 
parameters were set as for the simulations with a spatial resolution of 1.5 x 1.5 x 15 
mm, a constant flip angle of 25 º, a TE of 2 ms and a low-high (centric) phase order. 
To ensure that a steady-state had been established between heartbeats, ten start-up 
shots were used. Four signal averages were used. N = 1 was used to simulate the 
characteristics of blood.  
 
A scan with the IR or dual-IR sequence enabled but with the RF and gradients of the 
imaging sequence switched off was used to estimate noise. As for the phantom 
measurements performed for the QIR pre-pulse in chapter 3, the SNR was calculated 
for each sample using equation 3.6. The phantom was also scanned with no pre-
pulses and the TReff set to five times the longest T1 species. The SNR measurements 






relaxed magnetization in order to compare them to the simulated Mzb and Mzt 
values.  
5.2.4 Volunteer Studies  
In order to examine the signal suppression of the dual-IR sequence, three healthy 
volunteers were imaged at 3.0 T using a 32 channel coil without contrast 
administration. A single short axis slice was acquired using the same parameters as 
the patient studies (see below) but with N set to 13 for every heartbeat and 25 for 
imaging every 2 heartbeats. The effect of changing the number of start-up cycles was 
examined for both the IR and dual-IR sequences.  
5.2.5 Patient Studies 
Fifteen male patients (63 ± 8 years) with a history of MI at least 3 months prior and 
who were known to have LGE on previous clinical IR images were consecutively 
recruited between October 2010 and April 2011. Patients with contraindications for 
MRI were excluded. This prospective study was approved by the local ethics 
committee and all patients gave their written informed consent. All scans were 
performed using a 32-channel coil on a 3.0 T Achieva MR Scanner (Philips 
Healthcare, Best, the Netherlands). Three patients were used to optimize the MR 
protocol. The remaining twelve patients were then consecutively imaged as follows: 
after initial localizer scans, patients were administered 0.2 mmol/kg of Gadobutrol 
(Gadovist, Bayer Healthcare). Five minutes after contrast injection, breath-hold 2D 
IR segmented GE scans were performed to image three slices in the expected scar 
location on previous clinical LGE IR images. Imaging parameters included: spatial 
resolution = 1.5 x 1.5 x 10 mm, repetition time = 3.8 ms, echo time = 2 ms, two 
start-up shots, constant flip angle = 25 °, imaging every other heartbeat. The TFE 






was set to null the myocardium according to a preceding Look Looker scan. An 
imaging slice, which demonstrated the scar, was selected as the slice position for all 
subsequent single-slice images.  
  
The following scans were then performed at 10, 20 and 30 minutes post-contrast in 
the selected slice position. A Look Locker scan followed by a breath-hold 2D IR-
TFE sequence (parameters set as above). Dual-IR scans were then acquired with 
T1min set at 50, 100, 200 and 300 ms. All dual-IR scans were performed every 
heartbeat with the TFE factor adjusted to achieve a 12 second breath-hold for each 
patient. The order of the dual-IR scans was randomized for each patient prior to the 
start of the imaging session. In five of the patients, additional 2 or 4 chamber views 
were also acquired at 25 or 35 minutes post-contrast. 
5.2.6 Expert Analysis 
Short axis IR and dual-IR images taken at 20 minutes post-contrast were presented 
on different occasions in a random order to two blinded, independent experts, 
Amedeo Chiribiri and Andreas Schuster, who both have at least 5 years experience 
in cardiovascular MR. They were asked to identify the scars in each image and 
estimate the maximum transmurality of each scar as 0 - 25, 26 - 50, 51 - 75 and 76 - 
100 %. They also manually traced the borders of each identified scar using Osirix 
Imaging Software (version 3.2.1, Los Angeles, California) and gave each scar a 
confidence score for scar detection and transmurality assessment with 1) being 
negative low confidence, 2) negative medium confidence, 3) negative high 
confidence, 4) positive low confidence, 5) positive medium confidence and 6) 








Osirix Imaging Software (version 3.2.1, Los Angeles, California) was used to 
measure the mean signal intensity in regions of interest in scar, remote myocardium 
and left ventricular blood pool and the standard deviation of signal in the lung. The 
SNR of blood pool, myocardium and scar and the scar-to-blood CNR, scar-to-
myocardium CNR and blood-to-myocardium CNR were calculated for all short-axis 
images at all time points. 
5.2.8 Statistical Analysis 
 SPSS version 20 (IBM Software Group, New York, USA) was used to compare 
CNR and SNR measurements with a one-way Analysis of Variance between groups 
(ANOVA) which included both time after contrast administration and scan type as 
separate factors. A post-hoc Bonferroni test was performed to adjust for multiple 
comparisons. The differences between the confidence scores were compared using a 
Wilcoxon matched-pairs signed ranks test. The percentage of infarcts where the 
experts gave a different transmurality assessment was compared using a student t-
test. The inter-observer variability for the scar size was assessed using the Bland 
Altman test and the Pearson’s correlation coefficient. I made the assumption that if 




The TI1 and TI2 delays in the dual-IR pre-pulse were optimized for four different T1 







Figure 5­2: The TI1 and TI2 delays optimized to achieve signal suppression in four different T1 
ranges according to TReff. 
5.3.1.2 Simulation of Mzb and Mzt in the IR and dual­IR Sequences 
Mzt simulations for the IR sequence indicate that, for a heart rate of 60 bpm, a steady 
state is reached by the third heartbeat when imaging every heartbeat (Figure 5.3a) 
and by the second heartbeat when imaging every other heartbeat (Figure 5.3b). The 
Mzb simulations show that it takes seven heartbeats for blood to reach a steady state 
when imaging every heartbeat (Figure 5.3c) whereas a steady state is reached after 







































Figure 5­3: The simulated Mzt values in the IR sequence for each cardiac cycle for a heart rate 
of 60 bpm: a) imaging every heartbeat and b) imaging every other heartbeat and the simulated 
Mzb values for c) imaging every heartbeat and d) imaging every other heartbeat.  
 
The Mzt simulations for the dual-IR sequence show that, as with the IR sequence, 
three start-up cycles are required to reach a steady state when imaging every 
heartbeat (Figure 5.4a) whereas two are sufficient when imaging every other 
heartbeat (Figure 5.4b). The Mzb simulations show that, six cycles are required for 
blood signal to reach a steady state when imaging every heartbeat (Figure 5.4c). 
Once this is reached, the blood signal should be suppressed in the entire defined T1 
range. Only three cycles are required to reach a steady state when imaging every 
other heartbeat (Figure 5.4d), however the signal suppression within the T1-range 












































































Figure 5­4: The Mzt simulations in the dual-IR sequence for each cardiac cycle for a heart rate 
of 60 bpm a) imaging every heartbeat and b) imaging every heartbeat and the Mzb simulations 
c) imaging every heartbeat and d) imaging every heartbeat.  
5.3.2 Phantom Studies 
The Mzb at the time of imaging was plotted versus T1 for the IR and dual-IR 
sequences (lines in Figure 5.5a, b and c) and were in good agreement with phantom 
SNR measurements (markers). For the IR sequence the signal is zero only for one 
specific T1 value (T1 = 535 ms) while the signal is suppressed over a wide T1 range 
for the dual-IR sequence. In both sequences there is a relatively linear relationship 
between signal intensity and T1 for T1 values less than the null point or T1 min 
value, respectively. There is also a variation of both the IR and dual-IR signal 
characteristics with heart rate. In the dual-IR sequence the signal below T1min is 
suppressed to a greater extent for high heart rates (Figure 5.5b). For a constant heart 
rate, the range of signal suppression of the dual-IR sequence varies with the choice 

















































































Figure  5­5: Normalized Mzb values from simulations (lines) and SNR measurements from 
phantom experiments (points) for a) the IR sequence with TI chosen using the Fleckenstein 
formula [49] to null a T1 of 535 ms for normal myocardium derived from the Look Locker 
measurements at 20 minutes for each heart-rate and the dual-IR sequence with T1min=200 ms 
for different heart-rates and c) for the dual-IR sequence for a heart-rate of 75 bpm with 
different T1min values. Heart rate variation has little effect on signal suppression of long T1 
values (e.g. normal myocardium) but leads to variable suppression of tissues with short T1 
values. 
5.3.3 Volunteer Studies  
For the IR sequence, when imaging every heartbeat (images 5.6a-e), at least 2 start-
up cycles were required to overcome the ghosting artifacts caused by Mz 
modulation. When imaging every 2 heartbeats (images 5.6f-j), only 1 start-up cycle 
was sufficient to avoid significant ghosting. This is consistent with theoretical 
simulations which indicated that a steady state was established sooner when imaging 
every other heartbeat. For the dual-IR sequence, when imaging every heartbeat 
(images 5.6k-o), at least two start-up cycles were required to avoid ghosting and 
achieve suppression of the blood signal. When imaging every 2 heartbeats (images 























































cycle. It can also be seen that imaging every two heartbeats increases the signal for 
the short T1 species (e.g. the fat in the chest wall) compared to imaging every 
heartbeat. However, there appears to be inferior blood suppression in the right 
ventricle. From these results, it was decided to perform the IR sequence imaging 
every other heartbeat and the dual-IR sequence imaging every heartbeat both with 
two start-up cycles.  
 
Figure  5­6: Images in a volunteer (heart-rate 60 bpm) from left to right with: no start-up 
cycles, 1 start-up cycles, 2 start-up cycles, 3 start-up cycles and 4 start-up cycles using the IR 
sequence imaging every heartbeat (a-e) and imaging every 2 heartbeats (f-j), and the dual-IR 
sequence with T1min set at 200 ms, imaging every heartbeat (k-o) and imaging every 2 
heartbeats (p-t).  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Imaging was successfully performed in all patients. Patient characteristics are shown 
in Table 1.  
Age  
(Mean ± standard deviation) 63 ± 8 years 
Weight 84 ± 12 kg 
Heart rate 60 ± 8 bpm 
Scar age 60 ± 74 months 
LVEF*  44 ± 9 %.  
Male 100 % 
Diabetes 17 % 
Hypertension 83 % 
Smokers 42 % 
Hypercholesterolemia 58 % 
Previous percutaneous  
coronary intervention 83 % 
Previous coronary artery  
bypass graft 42 % 
Scar location† 
50 % inferior, 
17 % lateral, 
8 % anterior and inferior, 
25 % anterior / antero-septal.    
Table  5­1: Patient characteristics. *LVEF = left ventricular ejection fraction (measured on 
short-axis cine images in the previous MR clinical scan), †Scar location was assessed on previous 
clinical IR images.  
Representative images in one patient (Figure 5.7) show that the dual-IR sequence 
reduces the blood signal compared to the IR sequence. The level of blood signal 
reduction can be controlled by adjusting the T1min value. For the same T1min value, 
blood signal is reduced at later time points after contrast administration as the T1 of 
blood increases. The blood appears bright at all three time points for the IR sequence 











Figure 5­7: Representative image in a patient aged 62 years. Images in a short axis view taken 
at 10 minutes, 20 minutes and 30 minutes after contrast administration with the IR, dual IR 
with T1min = 50, 100 200 and 300 ms. Dual-IR images show reduced blood signal and improved 
scar delineation.  
 
IR images and dual-IR images taken at 20 minutes post-contrast with a T1min of 200 
ms in four patients (Figure 5.8) show that the dual-IR technique achieves blood 
signal reduction in all cases. Sub-endocardial scar appears to be more easily 
delineated with the dual-IR sequence. Four-chamber (Figure 5.9) and two chamber 
views taken (Figure 5.10) also show reduced blood signal with dual-IR technique 




































































Figure 5­8: Short axis images in 4 patients at 20 minutes after contrast administration using 
the IR sequence (left) and the dual-IR sequence (right) with a T1min of 200 ms. (a) 73 year old 
patient with antero-lateral, infero-lateral and inferior sub-endocardial scar, (b) 72 year old 
patient with sub-endocardial antero-lateral, infero-lateral scar with some atypical patchy 
enhancement in the septum, (c) 64 year old patient with extensive scar which is transmural in 
the anterior wall and subendocardial in the septum and (d) 66 year old patient with thin 
subendocardial antero-lateral, infero-lateral and inferior scar. Dual-IR images showed equally 
















Figure 5­9: Four-chamber view taken at 25 minutes after contrast administration of a patient 
(aged 66 years old) with a sub-endocardial basal to mid lateral wall scar with the IR sequence 
(a) and the dual-IR sequence with a T1min of 200 ms (b), and a patient (aged 72 years old) with a 
transmural basal to mid lateral wall scar with the IR sequence (c) and the dual-IR sequence 
with a T1min of 200 ms (d). As well as improved myocardial scar depiction, the dual-IR sequence 
appears to suppress the signal in the pleural effusion and allows visualization of contrast uptake 

















Figure 5­10: Two-chamber view taken at 25 minutes post contrast administration in a patient 
(aged 62 years old) with a transmural scar in the mid anterior wall and septum, which extends 
to the apex with the IR sequence (a) and the dual-IR sequence with a T1min of 200 ms (b) and a 
images taken at 35 minutes post-contrast administration of a patient (aged 70 years old) with a 
transmural basal to mid inferior wall scar and a small basal anterior wall scar with the IR 
sequence (c) and the dual-IR sequence with a T1min of 200 ms (d).   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Scar presence (Figure 5.11a) and transmurality assessment (Figure 5.11b) confidence 
scores were higher with the dual-IR sequence (with T1min of 100, 200 and 300 ms) 
compared to the IR sequence for both experts. The differences in transmurality 
confidence scores were significant for expert 1 when the IR sequence was compared 
to the dual-IR sequence with T1min of 100, 200 and 300 ms (p<0.05). With the dual-
IR sequence, there were fewer differences in transmurality assessment between the 
two experts compared to the IR sequence (Figure 5.11c). This was significant for the 










































Figure 5­11: a) Scar presence and b) transmurality assessment confidence scores from the two 
independent experts (1 and 2), (the bars show the statistically significant differences as assessed 
using the Wilcoxon matched-paired signed rank test p < 0.05). c) Percentage of scars in which 
there was a difference of 25 % in the transmurality between the two experts. The bars show the 



































































































































































There was also a trend towards a better agreement in scar size assessment with the 
dual-IR sequence with T1min values of 100 ms, 200s and 300 ms as shown in the 
Bland Altman plots (Figure 5.12). The Pearson’s correlation coefficient also 
demonstrated improved inter-observer variability for the dual-IR sequence. The R2 
value was 0.56 for the IR sequence (p = 0.002), 0.88 for the dual-IR sequence with 
T1min = 50 ms (p<0.001), 0.93 for the dual-IR sequence with T1min = 100 ms 
(p<0.001), 0.89 for the dual-IR sequence with T1min = 200 ms (p<0.001) and 0.94 for 




























Figure 5­12: Bland Altman plots examining the difference in the scar size assessment between 
the two experts for a) IR images, b) dual IR images with T1min = 50 ms, c) dual IR images with 
T1min = 100 ms, d) dual IR images with T1min = 200 ms and dual IR images with T1min = 300 ms. 
Solid line indicates the mean of the differences and the dashed lines indicate 1.96 standard 
deviations above and below the mean of the differences. 
5.3.6 SNR and CNR Measurements 
When all time points were considered together, the blood SNR was found to be 
significantly higher for the IR sequence compared to the dual-IR sequence for all 
T1min values (p < 0.05) (Figure 5.13a). There was no significant difference in the 
myocardium SNR between the IR and the dual-IR sequence for any of the T1min 
values. A significant reduction in scar SNR was only found between the IR and the 














The scar-to-blood CNR was found to be significantly higher in the dual-IR sequence 
with all T1min values compared to the IR sequence (p = 0.013, 0.009, 0.007 and 
0.003 for T1min of 50, 100, 200 and 300 ms respectively) (Figure 5.13b) . The scar-
to-myocardium CNR was however found to be significantly higher for the IR 
sequence compared to the dual-IR sequence for all T1min values (p = 0.013, 0.01, 
0.033 and 0.02 for T1min of 50, 100, 200 and 300 ms respectively) (Figure 5.13c). 
Although reduced compared to the IR sequence, the scar-to-myocardium CNR in the 
dual-IR sequence is still probably adequate to differentiate the scar from normal 
myocardium. The blood-to-myocardium CNR was also found to be significantly 
higher in the IR sequence compared to the dual-IR sequence with all T1min values (p 







































Figure  5­13: a) Blood SNR, b) scar-to-blood CNR, c) scar-to-myocardium CNR values 
calculated in short-axis IR and dual-IR images at the three different time points after contrast 
administration. Points are for each scan type at 10, 20 and 30 minutes post contrast 
administration but have been shifted slightly to improve visualization of the error bars. 
Significant differences between time points are displayed from one-way Analysis of Variance 
between groups (ANOVA) which considered all scan types together. A post-hoc Bonferroni test 
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Simulation and phantom studies show that the dual-IR sequence allows signal 
suppression over a wide T1 range which can be adjusted by changing the T1min 
value. Preliminary patient data show improved scar-to-blood contrast, confidence 
scores for the presence of infarction and the extent of transmurality for the dual-IR 
sequence compared to the IR sequence. There was improved consistency between 
the two experts for assessment of scar size and extent of transmurality with the dual-
IR sequence. The highest confidence scores were given to the dual-IR sequence with 
a T1min of 200 ms, which may be due to a combination of sufficient left ventricular 
blood reduction combined with good visualization of the myocardium. Shorter T1min 
values resulted in lower blood signal whereas longer T1min values provided higher 
blood-to-myocardium CNR which improved myocardium visualization and border 
definition. 
 
The ability to differentiate irreversibly damaged from normal myocardium is a key 
advantage of MR over other imaging modalities. The assessment of transmurality 
and the detection of small sub-endocardial scar can be hindered by the poor scar-to-
blood contrast in IR images. A new LGE MR sequence was recently described 
which employs an additional slice selective pulse to prepare the blood and 
myocardium magnetization differently in order to achieve black blood properties 
[37]. This relies on sufficient blood flow between the slice-selective and non-
selective inversion pulses and it was found to work less reliably in patients with an 
ejection fraction of less than 40 % [37]. In addition, this approach still relies on the 
exact timing of inversion pulses to suppress the two individual T1 values of blood 







The dual-IR sequence is a modification of the QIR sequence, which was developed 
to achieve T1-independent blood suppression in carotid plaque imaging [29]. 
Whereas in the QIR sequence, the aim was to null only the blood signal, I have 
shown that the dual-IR sequence achieves blood and tissue signal suppression within 
the defined T1-range. It is not dependent on out-flow of blood from the imaging slice 
and should therefore be applicable to patients with low ejection fractions which is 
important for imaging patients with myocardial scar.  
 
Papillary muscle enhancement has been linked to ventricular arrhythmias [101] and 
mitral regurgitation [102]. The depiction of papillary muscle scar such as in Figure 
5.8d also seems to benefit from the reduced blood signal of the dual-IR sequence. I 
hypothesize that the dual-IR technique may also be useful in the imaging of diffuse 
fibrosis, amyloidosis or myocarditis where contrast uptake is more diffuse making 
the correct choice of TI often difficult. It may also aid the visualization of scar 
formation following radio frequency ablation procedures where differentiation of the 
scar from blood can be hampered by high blood signal in IR images. 
 
This study successfully demonstrates proof-of-concept but consequently also has 
limitations. I only investigated 12 patients with a wide range of scar chronicity. 
Instead of covering the entire left ventricle, I only tested the sequence in a single 
slice with confirmed scar on the IR sequence. However, this approach minimized the 
time between the IR and dual-IR sequence in order to allow comparison of both 
sequences at different times points post contrast injection. I also used identical read-






imaging sequence on image contrast. In order to achieve an identical 12 second 
breath-hold for the IR and dual-IR images, the TFE factor and the acquisition time 
were approximately double for the IR images, which may have increased image 
blurring in some cases. SENSE acceleration, which could have been used to reduce 
the acquisition time, was not employed in order to allow an accurate calculation of 
the SNR and CNR values. The patients included in this study had heart-rates 
between 50 and 70 bpm. As the simulations showed that there is more signal 
suppression at higher heart-rates, I would recommend that for patients with a heart-
rate >75 bpm the dual-IR pre-pulse is played out over the time period of two RR 
intervals. This would aim to produce signal characteristics that would be achieved at 
half the heart rate and should ensure the signal in the scar is maintained.  
 
I have also only tested the dual-IR sequence using Gadovist with a dose of 0.2 
mmol/kg. This is consistent with accepted international guidance for LGE imaging 
[85]. However, a lower dose may have produced less marked differences in blood 
signal between the two sequences especially at later time points after administration. 
The dual-IR technique also relies on the fact that the T1 of scar is below the T1 
suppression range to ensure the scar itself is not suppressed. In this study, scar was 
never suppressed using the dual-IR sequence at any time point even with a T1min of 
50 ms. Future work should include an investigation of different contrast agents, 
doses, field strengths and include a range of infarct ages. In order to make a direct 
comparison between the sequences, analysis of the transmurality, scar presence and 
scar size data was only performed on the 14 infarcts that were identified by both 
experts in all the images. In 4 patients, there were additional infarcts identified on 






sequence should be validated in a large animal study to allow testing of the accuracy 
of this technique. This would be useful to determine whether scars that were 
identified on IR images but excluded on the dual-IR images and vice-versa were 
present on histology.  
 
Although there are a number of automated methods for scar size assessment, I 
decided to use manual segmentation to assess scar size. In an extension of this study, 
I could evaluate automated techniques like the FWHM or standard deviation models 
to quantify scar size in the dual-IR images.  
 
In conclusion, I have developed a dual-IR sequence that achieves adjustable tissue 
suppression over a wide T1 range. Preliminary patient data show the dual-IR 
sequence results in an improvement in scar-to-blood CNR, higher expert confidence 
with regard to the presence of scar and the assessment of scar transmurality and 
more consistent assessment of scar size and transmurality between experts compared 








6. Review of  LGE MRI Techniques  for  Scar Visualization  after 
RF Ablation for PVI  6.1 Introduction 
LGE is a well validated technique for visualizing ventricular scar. Lardo et al (2000) 
first described the LGE effect in the right ventricle of a canine model following RF 
ablation [103]. Dickfeld et al (2006) then studied the formation of lesions in the 
epicardium of dogs up to 12 hours after RF ablation [104]. There was also a case of 
ventricular scarring reported in a patient who had undergone previous RF ablation 
for idiopathic LV tachycardia [105]. This led to studies investigating whether the 
LGE may be useful for visualizing areas of atrial scar in patients who have 
undergone RF ablation for arrhythmia.  
 
There are several additional challenges when applying the LGE technique to atrial 
scar. Firstly, the atria are up to five times thinner than the myocardium. This means 
that improved spatial resolution and excellent respiratory and cardiac motion 
compensation are required. Secondly, the ultimate clinical aim is to overlay the LGE 
scar distribution onto a 3D anatomical model of the atria and PVs created from MR 
angiography images and to compare this with 3D maps of EP data. A 3D acquisition 
is therefore preferred with improved through plane spatial resolution so thin 
contiguous slices can be reconstructed and a 3D map of the scar can be reformatted. 
Thirdly, as the pulmonary anatomy is complex and varies between individuals, it can 
be difficult to use the expected anatomy to differentiate scar from blood and normal 
atrial wall. There must therefore be high image contrast between scar and atrial wall 
and between scar and blood. Fourthly, the patients are being treated for arrhythmias 
which present challenges for all ECG-triggered MR sequences. This chapter will 







Peters et al (2007) performed LGE MR imaging on patients before and after 
pulmonary vein isolation (PVI) procedure using RF ablation [25]. The sequence used 
in this study has become the standard approach for LGE atrial scar imaging. It was 
adapted from 3D LGE sequences used for the myocardium and coronary arteries 
[106, 107]. Whereas a 2D acquisition only excites a single slice, a 3D acquisition 
excites an entire volume. The 3D volume is spatially encoded with phase encoding 
along two orthogonal directions and frequency encoding along the third. The raw 
data is collected in a 3D k-space, which is then reconstructed using a 3D Fourier 
transform. The 3D acquisition thus allows thin contiguous slices to be reconstructed, 
which are ideal for visualizing LGE in the atrial wall and PVs. However, because 
phase encoding is performed along two axes, the scan time is prolonged with 3D 
acquisitions. On the other hand, the SNR is improved for a 3D acquisition compared 
to a 2D acquisition with the same spatial resolution. 
 
A TReff of 1 heartbeat is used which allows less time for T1 recovery between 
heartbeats but reduces the overall scan time. A flip angle of 15 - 25 ° is used to 
minimize the effect of the read out on the image contrast. In order to visualize the 
thin atrial wall, the acquired voxel size is 1.3 x 1.3 x 5 mm, which is then 
reconstructed to 0.6 x 0.6 x 2.5 mm. Fat suppression is used to suppress the signal 
from epicardial fat.  6.3 Cardiac and Respiratory Motion Compensation 
In order to reduce the artifacts caused by cardiac motion, a balanced steady state free 
precession (b-SSFP) cine image is usually used to ascertain the period in the cardiac 
cycle when the atria are most still. As this varies with the patient’s heart-rate, it is 
performed on an individual basis. The trigger delay and acquisition window are set 
to perform image acquisition during this quiescent period.  
As the 3D LGE scan time is far too long for a breath-hold, a respiratory navigator is 
required. A navigator is performed by exciting a cylindrical beam of tissue 
perpendicular to the liver-lung interface. The k-space data acquired from this beam 






acquired just before image acquisition and provides a measurement of the diaphragm 
position in the superior-inferior direction (Figure 6.1). In order to reduce the artifacts 
caused by respiratory motion, an acceptance window around end-expiration is 
defined and only the image data acquired at this respiratory phase are reconstructed. 
A wider acceptance window will result in more data being accepted and a shorter 
scan time however it could also increase motion artifacts. In general, an acceptance 
window of 5-7 mm is employed, which results in a scan of 5-10 minutes. 
 
Figure 6­1: Respiratory navigator placement over  the  liver­lung  interface (left) and  the 
definition of an acceptance window to only reconstruct data at end expiration (right).  
 
In order to detect the position of the liver-lung interface, there must be sufficient 
signal in the liver at the time when the navigator data is acquired. If an inversion pre-
pulse has been employed, this can suppress the liver signal which can hamper 
navigator detection. Therefore when the IR-TFE is combined with a navigator, a 
restore pulse is applied immediately after the inversion pulse, which restores the 
signal in an area slightly larger than the area of the cylindrical beam navigator 
(Figure 6.2) [109]. This restores the magnetization within that region and means 








Figure 6­2: The navigator  restore pulse  is  applied  to  ensure  sufficient navigator  signal 
when IR­TFE imaging is combined with a respiratory navigator [38].  
Although the restore pulse improves navigator detection, it also has an undesired 
effect. The restore pulse can re-invert the signal of blood in the PVs. By the time of 
image acquisition, this blood may have flowed into the PV ostia and atria. This can 
cause bright signal in the PVs and atria and can hamper the detection of scar (Figure 
6.3). In addition, there is often a circle of bright signal where the navigator restore 
pulse was applied, which affects the dynamic range of the image. This means the 
brightest signal will be in the area of the navigator restore and any LGE areas in the 










There have been several approaches aimed at reducing the PV in-flow artifact. 
Firstly, respiratory bellows can be used as alternative method of respiratory gating. 
Peters et al (2011) compared respiratory navigation with bellows and found that the 
bellows removed the PV in-flow artifact and there was no significant difference in 
image sharpness or ghosting [110]. However, this was a pilot study on only nine 
subjects and not all centers have bellows available for clinical use.  
 
Hedjazi-Moghari, et al (2010) implemented an alternative approach where the 
restore pulse after the inversion pre-pulse is taken out, which removes the high 
signal in the liver and the PV in-flow artifact [38]. They also replaced the pencil 
beam navigator with a projection navigator, which is less sensitive to off-resonance 
effects. In order to achieve sufficient signal in the liver, a delay must be inserted 
between the navigator acquisition and image acquisition (Figure 6.4). The delay 
between the projection navigator and image acquisition should be long enough in 
order to obtain sufficient signal in the liver. They performed a pilot study on five 
subjects where they performed a Look Locker scan to measure the liver signal with 
variable inversion times. They found that a delay of 100 ms provided sufficient liver 
signal for navigator detection. The disadvantage of this approach is that the 
diaphragm position is measured 100 ms before the image acquisition, which 
precludes the use of motion tracking and thus has the potential to induce residual 
motion artifacts. In this study on 18 subjects however they found no statistically 
significant difference between subjective motion scores artifacts between the 
“restore” and “no restore” approaches. 
Figure 6­4: The sequence design for with navigator restore a projection navigator and a 
delay before imaging [38].  
Badger et al (2010) used an alternative approach to reduce the effect of the PV in-






image acquisition by which time the magnetization in the liver has achieved 
sufficient recovery to allow navigator detection [27].   6.4 Contrast Agents and Timing of Image Acquisition 
In order to visualize areas of scar, the signal from normal atrial wall and blood 
should be suppressed. In the IR-TFE sequence, the inversion time, TI, is usually set 
to null the signal from normal myocardium using a preceding Look Locker scan. 
This makes the assumption that the normal atrial wall has the same T1 value as 
normal myocardium [25]. An alternative approach would be to choose the TI to null 
the blood signal but this may result in suboptimal nulling of the unscarred atrial wall.  
 
There have been several studies which perform LGE imaging with the 3D IR-TFE 
technique using different contrast agents and timing. Some have used a single dose 
of Multihance and performed LGE imaging at 15 minutes post-contrast 
administration [26, 27, 111, 112]. One study used a dose of 0.15 mmol/kg of 
Magnevist and imaged at 15 minutes post contrast administration [113]. Those 
studies that used a double dose of Magnevist imaged at 15 to 25 minutes after 
administration [25, 114-116].  
 
When designing the best protocol for 3D-IR-LGE imaging, it is desirable to wait 
until the T1 of the blood is sufficiently longer than that of scar so that the IR-LGE 
technique will result in good scar-to-blood contrast. Goldfarb et al (2009) and Klein 
et al (2004) suggested that for a double dose of Magnevist, a time delay of more than 
15 minutes is required to ensure sufficient scar to blood differentiation [86, 87]. The 
drawback of imaging after 20 - 25 minutes is a longer total scan time and decreased 
patient throughput. 6.5 Data Analysis  
In order to relate the scar seen on LGE images to patient outcome, it is useful to 
quantify the total amount of scar and scar thickness and to assess the circumferential 
extent of scar around a PV. This section will outline some of the approaches to scar 
quantification and assessment, which are based either on manual contouring or 







The methods used for the quantification of scar extent are based on studies 
performed on ventricular scar after MI (described in section 4). McGann et al (2008) 
and Badger et al (2010) measured the extent of injury using a threshold based 
algorithm. Firstly, the contours of the epicardial and endocardial borders were 
manually defined to confine the analysis to the LA wall. Injured tissue is then 
defined as three standard deviations above the mean pixel signal intensity in normal 
atrial wall.  
 
Peters et al (2009), did not use contouring to exclude the blood pool but instead 
employed a user defined threshold, which was optimized on a patient by patient 
basis. The minimum threshold that eliminated most blood pool was chosen. After 
thresholding, isolated high signal pixels were removed. The authors accept that his 
user dependent approach adds subjectivity to the analysis but report good inter and 
intraobserver agreement in a previous study [116]. 
6.5.2 Circumferential Extent 
As the RF ablation procedure aims to isolate the PVs, the circumferential extent of 
scar is a potential measure of how well the PV has been isolated. In Peters et al 
(2009), an expert was asked to estimate the circumferential extent to the nearest 5 % 
in maximum intensity projected (MIP) images [114]. This allowed them to visualize 
scar in an image of the cross-sectional of the ostia of the PV.  
6.5.3 Scar Thickness 
The thickness of scar is thought to be linked with the efficacy of the ablation. It is 
however a difficult parameter to accurately measure as the atrial walls are very thin. 
In Peters et al (2009), scar thickness was measured using line profiles perpendicular 
to the septum [114]. A significant inverse relationship was found between thickness 
of enhancement and the number of days after ablation procedure.  
 
Although the technique described in McGann is automated, it still requires the user 
to define the scar-blood border to exclude the blood signal. Although the technique 
used by Peters et al (2009) does not exclude the blood pool analysis; it means that 






by threshold technique. Equally when measuring the thickness of scar and the 
circumferential extent, the inclusion of blood pixels as scar will lead to a misleading 
result.  6.6 Correlation of Atrial LGE  with Arrhythmia Recurrence  
McGann et al (2008) performed LGE imaging before and three months after RF 
ablation for PVI in 46 patients with AF [26]. Arrhythmia recurrence correlated with 
the degree of wall enhancement. LGE was not seen in any of the pre-ablation scans 
whereas it was seen in all post-ablation scans. Patients with minimal scar were found 














Peters et al (2009) performed a similar study investigating the relationship between 
the recurrence of (AF) and the extent of LGE after the PVI procedure [114]. They 
performed LGE imaging 46 ± 28 days after RF ablation around each PV ostium in 
35 patients with AF. They found that patients without recurrence had more 
completely circumferentially scarred veins based on a qualitative measurement of 
scar extent. Patients without recurrence also more frequently had scar in the inferior 
region of the right PV. The quantitative measure of the volume of scar was greater in 
patients without recurrence. Badger et al (2010) performed a more extensive study 






[27]. They found that the number of PVs with complete circumferential scarring and 
the total left atrial scar was significantly higher in patients with a better clinical 
outcome. 6.7 Correlation of LGE Atrial Scar with EP Data 
Taclas et al (2010) performed a study to compare the post procedural LGE scar in 19 
AF patients with the intended sites of RF ablation [115]. They performed a rigid 
registration of the LGE scar data with the Carto data which is an EP mapping 
technique which shows the locations of intended ablation points in relation to the PV 
and atrial anatomy. They then measured the distance between the Carto points with 
the nearest scar. They found that although there was a correspondence between the 
Carto points and the scar, for 20 % of the Carto ablation sites there was no visible 
corresponding scar. They found that those with recurrent AF had significantly more 
gaps in the left inferior PV. As it is difficult to determine the efficacy of each 
ablation point during the procedure, they speculated that LGE scar imaging may help 
to evaluate which ablation points have been ineffective.  6.8 Use of LGE Atrial Scar to Plan Repeat RF Ablations  
Reddy et al (2008) reported on a case of a patient who had multiple unsuccessful 
ablations for AF/AFL [117]. They found that the regions devoid of scar on LGE 
images corresponded to the sites with early electrical activation. After these areas 
were ablated, electrical PV reconnection did not occur and the patient remained free 
of AF and AFL. Badger et al (2010) performed a more extensive study on 144 
patients, 18 of which underwent a re-ablation procedure [27]. They found that the 
LGE shown at 3 months after the initial RF ablation correlated with the EP data 
during the 2nd procedure (Figure 6.6). In those patients who had a second re-ablation 
procedure, the gaps in the LGE pattern were identified and used to target the second 
ablation procedure. In one patient, all four PVAs had incomplete isolation. After the 
second ablation procedure, there were circumferential lesions around all four PVAs 












map  obtained  during  the  repeat  procedure  for  3  patients.  The  images  on  the  left 
demonstrate PA  (top) and AP  (bottom) views of  the DE­MRI color model  scar patterns. 




Figure 6­7: 3D MRI model of the LA after failed PVA isolation (First) and repeat successful 
PVA isolation (Second). After the initial failed ablation, all 4 PVs showed incomplete PVA scar 
as evident by lack of continuous scar (orange/white) around each PV ostia (white outline). Gap 
lesions of healthy myocardium (blue) were identified and targeted (yellow arrows) before repeat 













7. Dual­IR  Pre­pulse  for  LGE  imaging  of  RF  Ablation  Lesions 
after PVI for AF 7.1 Introduction  
7.1.1 Scar Imaging 
A good correlation has been found between the extent of LGE in atrial scar using the 
IR technique and the outcome in patients who have undergone PVI using RF 
ablation for AF [114]. However, scar visualization can be hampered by strong 
residual blood signal. Therefore imaging is often performed at least 25 minutes after 
contrast administration to ensure the contrast agent has cleared from blood [86]. 
Chapter 5 described how the dual-IR pre-pulse was shown to improve blood 
suppression in LGE images of myocardial scar. In this chapter I describe a study to 
assess whether the dual-IR pre-pulse improves blood suppression in LGE atrial scar 
imaging and whether it allows imaging earlier after contrast administration.  
7.2 Methods 
7.2.1 Pulse Sequence 
The standard 3D free breathing, respiratory-navigated, ECG-triggered GE sequence 
was employed on a 1.5 T Achieva MRI scanner (Philips Healthcare, Best, The 
Netherlands) [114]. Image acquisition was timed with the minimal atrial motion 
using a preceding balanced steady state free precession (bSSFP) cine image. Imaging 
parameters included: TE / TR = 2.6 / 5.4 ms, navigator window = 5 - 7 mm, flip 






sequence was combined with the traditional IR pre-pulse with the TI set to null 
normal myocardium using a preceding Look Locker scan.  
 
The sequence was also combined with the dual-IR pre-pulse. As for the myocardial 
scar imaging described in chapter 5, it consisted of two non-selective inversion pre-
pulses separated by two time delays TI1 and TI2. The optimal suppression range was 
found to be 200 - 1400 ms or 300 - 1400 ms in the infarct study. Therefore in the 
atrial scar patients, the TI1 and TI2 delays were optimized to achieve signal 
suppression in a T1 range of 250 - 1400 ms according to the heart-rate. In the infarct 
study, all the patients had heart-rates in the range of 50 to 70 bpm. The atrial scar 
patients had a wider range of heart-rates. From the results of simulations and 
phantom studies in chapter 5, it was clear that for heart-rates ≥ 80 bpm, the dual-IR 
sequence results in greater suppression of shorter T1 species (Figure 7.1). It is 
therefore possible that the scar signal will be suppressed in the dual-IR sequence at 








Figure 7­1: Simulations and phantom measurements of Mzb versus T1 value for T1min = 250 ms 























In the dual-IR sequence, it was decided therefore to apply the GE read-out every two 
heartbeats in patients with heart- rates ≥ 80 bpm. For example, in a patient with a 
heart-rate of 90 bpm, the TI1 and TI2 delays were optimized for a heart-rate of 45 
bpm and the two inversion pulses are played out during the time of two RR intervals 
(Figure 7.2). The IR-TFE sequence on the other hand was applied every heartbeat in 






Figure 7­2: The dual-IR pulse sequence applied with the two inversion pulses distributed over 
two heartbeats for high heart-rates. 
7.2.2  Implementation of an Alternative Navigator Sequence 
As described in chapter 6, Moghari et al described an alternative navigator strategy 
to remove the PV in-flow artifact [38]. I implemented this strategy using a pencil 
beam navigator and combined this with the IR and dual-IR pre-pulses. It was tested 
in one patient 25 - 30 minutes after contrast administration using the IR-TFE 
sequence described above by scanning with and without the navigator restore to 
compare the presence of the PV in-flow artifact. It was then applied in all of the 
following patient studies.  
7.2.3 Patient Studies  
Thirteen patients (10 male, age 57 +/- 10yrs) underwent MR imaging using a 1.5 T 
clinical MR scanner (Philips Healthcare, Best, the Netherlands) approximately 3 















part of an existing study at this field strength. Imaging was performed after 0.2 
mmol/kg of gadopentate dimeglumine (Magnevist, Bayer Schering AG, Berlin) was 
administered. Dual-IR-TFE imaging was performed at 15, 20 and 30 minutes and 
compared to standard IR-TFE imaging at 25 minutes. To perform a direct 
comparison of the IR and dual-IR pre-pulses, in one patient imaging was performed 
with the IR sequence at 15, 20, 30 and 40 minutes after contrast administration and 
then repeated in the same patient in a second scanning session using the dual-IR 
sequence at the same time points. 
7.2.4 SNR and CNR Measurements 
Regions of interest were manually defined in 5 slices in the blood and right superior 
PV scar in all images. Blood and scar SNR and scar-to-blood CNR values were 
measured using Osirix software.  
7.2.5 Scar Quantification 
For each 3D image set, two readers both with at least 2 years experience in cardiac 
MRI (James Harrison and Zhong Chen) manually segmented areas of late 
enhancement around the PVs and left atrium. The total scar size was measured using 
ITK-SNAP Medical Image Segmentation software (http://www.itksnap.org) [118].  
7.2.6 Statistical Analysis 
The SNR and CNR values were compared using a paired t-test between the IR 




LGE images using the IR sequence combined with standard navigator was found to 






displayed high signal in the liver (large arrow in Figure 7.3c) which affects the 
dynamic range of the images and can make it more difficult to visualize scar in the 
atrial wall Images in the same patient with the navigator restore removed and a delay 
inserted between the navigator and imaging were found to remove the pulmonary in-
flow artifact (7.3b) and the bright signal in the liver due to the navigator restore 
(7.3d)  
 
Figure 7­3: LGEimages using the IR sequence combined with standard navigator (a and c) and 
images in the same patient with the navigator restore removed and a delay inserted between the 
navigator and the imaging read-out (b and d).  
 
7.3.2 Patient Studies 
Dual-IR-TFE images achieved superior blood suppression at an earlier time point 
compared to IR-TFE images (Figure 7.4). Images in the same patient taken in two 
separate scanning sessions show that the dual-IR pre-pulse achieves improved blood 









Figure  7­4: LGE images of atrial scar in a 66-year-old female patient: IR imaging at a) 25 
minutes and dual-IR imaging at b) 15 minutes, c) 20 minutes and d) 30 minutes after contrast 
administration. All images have identical windowing.  
Figure 7­5: LGE images of atrial scar in a 68-year-old male patient taken during two separate 
scanning sessions. Images from the first scanning session using the IR-TFE sequence at a) 15 
minutes, b) 20 minutes, c) 30 minutes and d) 40 minutes after contrast administration Images 
from second scanning session using the dual-IR GE sequence at e) 15 minutes, f) 20 minutes, g) 
30 minutes and h) 40 minutes after contrast administration. All images have identical 
windowing.   
7.3.2 SNR and CNR Measurements 
Blood SNR values were significantly reduced at all time points in the dual-IR images 
compared to IR images at 25 minutes (Figure 7.6a.) whereas there was no significant 
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difference in scar SNR (Figure 7.6b.). Scar-to-blood CNR values were significantly 






Figure 7­6: Blood SNR, b) scar SNR and c) scar-to-blood CNR measurements for IR and dual-
IR images. Horizontal bars indicate statistical significance in a paired t-test p<0.05. 
7.3.3 Scar Quantification 
There was no statistically significant difference between the scar size between the IR 
at 25 minutes and dual-IR images at 20 minutes for either observer. Bland Altman 
plots and correlation plots show an improved interobserver variability for total scar 
measurements for the dual-IR sequence at 20 minutes compared to the IR sequence 














































at  25  minutes  and  b)  dual­IR  sequence  at  20  minutes.  Correlation  plots  for  c)  the  IR 
sequence at 25 minutes and d) dual­IR sequence at 20 minutes. 7.4 Discussion 
RF ablation strategies have evolved from ablating anywhere within the PV to wide 
encircling lesions around the PV antrum and additional RF energy applications 
targeting anatomic areas and EP parameters.[119] Despite this, single procedure 
success rates are modest, suggesting that the factors which contribute to acute 
electrical isolation are not well understood.[120] LGE imaging using the IR 
sequence has been used to visualize and quantify post-procedural RF lesions in vivo. 
It has also recently been used to guide repeat procedures and identify gaps between 
areas of previous ablation.[27] The dual-IR technique improves visualization of left 
atrial LGE areas with improved atrial blood pool suppression and better definition of 

















































































































The dual-IR technique achieves improved blood suppression and an improvement in 
the inter-observer variability in scar size quantification. As imaging can be 
performed earlier, it also has the potential to reduce the overall scan time which may 
improve patient compliance and optimize resources. The traditional IR method 
requires a Look Locker sequence to calculate the optimum inversion delay to ensure 
optimum nulling to visualize areas of LGE. The dual-IR sequence mitigates this step 
as the inversion delays are automatically calculated according to the patient’s heart-
rate. The combination of the dual-IR sequence with the new respiratory navigator 
implementation, removed the PV artifact which can hamper the visualization of scar. 
 
The patient sample size was small so it can only be considered a proof-of-concept 
study. In addition, all the patients were in sinus rhythm so it would be useful to also 
examine the image quality in patients in AF. As future work, the extent of scar 
measured in the dual-IR and IR images could also be correlated with the recurrences 
in these patients to determine which sequence is better at predicting procedural 
success. An animal model could also be used to see if the dual-IR sequence produces 
a more accurate map of the scar by comparing to histology.  
 
In conclusion, dual-IR improves blood suppression in LGE imaging and improves 










Cardiovascular MRI employs many different pulse sequences to provide 
morphological and anatomical information and to characterize disease. Although it 
has a variety of endogenous contrast mechanisms, gadolinium based contrast agents 
are often used to improve the conspicuity of disease. LGE imaging can be performed 
to visualize some components of atherosclerotic plaques. It is hoped that eventually 
this will be used as a screening tool to help differentiate vulnerable from stable 
plaques. Arguably, the most important application of LGE imaging is for the 
visualization of myocardial scar after MI. It is a well established technique which 
can determine the presence, extent and transmurality of scar. This was shown to help 
predict the likelihood of functional recovery after revascularization therapy. More 
recently, LGE imaging has been used to visualize atrial wall scar in patients who 
have undergone RF ablation therapy for AF. It was found that the extent of scar in 
the atrial wall correlated with procedure success and that the LGE pattern could be 
used to plan re-do ablation procedures. The aims of this work were to develop, 
optimize and test novel MRI pulse sequences for LGE imaging of the aortic vessel 
wall and myocardial and atrial wall scar. 
 
Traditionally the DIR sequence has been used to achieve black blood images of the 
vessel wall. In the DIR sequence, blood only experiences one non-selective inversion 
pulse which means that there is one inversion time which can be optimized to 
suppress blood signal resulting in the nulling of only one specific T1 value. When 






achieve blood suppression. The correct determination of TI is therefore user-
dependent and requires a Look Locker scan. The QIR sequence works on the 
principal that two inversion pulses with two delay times can be optimized to achieve 
blood suppression both before and after contrast administration using identical 
imaging parameters. The original implementation of the QIR sequence was applied 
to the carotid arteries and did not employ ECG-triggering [29]. To use the QIR 
sequence to image the aorta, I hypothesized that as there is variable flow during the 
cardiac cycle, the QIR sequence should be combined with ECG-triggering. I 
therefore had to optimize the TI1 and TI2 delays according to the patient’s heart-
rate. I also tested two types of ECG triggering in 10 volunteers which showed that 
the TI2 delay must be timed to coincide with systolic flow in the aorta to achieve 
sufficient out-flow and blood suppression. I also found that the QIR sequence could 
be combined with zoom imaging to accelerate the image acquisition. The 
modification of the QIR pre-pulse means that the sequence can now be successfully 
employed in vessels which have variable flow or motion during the cardiac cycle.  
 
LGE imaging using the IR sequence is routinely used to visualize myocardial scar. 
Because the IR sequence only nulls the signal from one T1 species (the normal 
myocardium), there is often remaining signal in the blood pool. If the blood signal is 
sufficiently high, it can sometimes be difficult to distinguish scar from the adjacent 
blood pool particularly for subo-endocardial or small areas of scar. As was shown in 
my work to optimize the QIR sequence, two inversion pulses separated by two 
delays can be optimized to achieve signal suppression in a wide T1 range. I thus 
decided to apply this principle to LGE imaging of myocardial scar. I developed the 






suppression in different T1 ranges: 50-1400 ms, 100-1400 ms, 200-1400 ms and 
300-1400 ms. I tested this sequence in 12 patients with myocardial scar and found 
improved blood suppression and scar-to-blood CNR using the dual-IR sequence 
compared the traditional IR sequence. I also found that there was improved inter-
observer variability for the manual assessment of transmurality and scar size.  
 
In the third study, I evaluated the dual-IR sequence for the visualization of atrial scar 
in 13 patients who had undergone RF ablation for AF. I found that the dual-IR 
sequence with a T1min value of 250 ms improved blood suppression compared to the 
IR sequence with TI optimized to null normal myocardium. I also found that the 
dual-IR sequence improved the inter-observer variability of scar size measurements 
and enabled imaging earlier after contrast administration.  
 I  aimed  to  develop  novel MRI sequences for LGE imaging which involved 
theoretical simulations, phantom experiments, volunteer and patient studies to 
optimize and test the new sequences. I have demonstrated that the novel QIR 
implementation and dual-IR sequence are robust and applicable to several different 
cardiovascular diseases. The initial results in volunteers and patients show that the 
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